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ABSTRACT

CONTROLLING FOR CONFOUNDING WHEN ASSOCIATION IS QUANTIFIED BY
AREA UNDER THE ROC CURVE
By Hadiza I. Galadima, Ph.D.
A dissertation submitted in partial fulfillment of the requirement for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2015
Advisor:
Donna K. McClish, Ph.D.
Professor, Department of Biostatistics

In the medical literature, there has been an increased interest in evaluating association
between exposure and outcomes using nonrandomized observational studies. However, because
assignments to exposure are not done randomly in observational studies, comparisons of
outcomes between exposed and non-exposed subjects must account for the effect of confounders.
Propensity score methods have been widely used to control for confounding, when estimating
exposure effect. Previous studies have shown that conditioning on the propensity score results in
biased estimation of odds ratio and hazard ratio. However, there is a lack of research into the
performance of propensity score methods for estimating the area under the ROC curve (AUC). In
this dissertation, we propose AUC as measure of effect when outcomes are continuous. The
AUC is interpreted as the probability that a randomly selected non-exposed subject has a better
response than a randomly selected exposed subject. The aim of this research is to examine
methods to control for confounding when association between exposure and outcomes is
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quantified by AUC. We look at the performance of the propensity score, including determining
the optimal choice of variables for the propensity score model. Choices include covariates related
to exposure group, covariates related to outcome, covariates related to both exposure and
outcome, and all measured covariates. Additionally, we compare the propensity score approach
to that of the conventional regression approach to adjust for AUC. We conduct a series of
simulations to assess the performance of the methodology where the choice of the best estimator
depends on bias, relative bias, mean squared error, and coverage of 95% confidence intervals.
Furthermore, we examine the impact of model misspecification in conventional regression
adjustment for AUC by incorrectly modelling the covariates in the data. These modelling errors
include omitting covariates, dichotomizing continuous covariates, modelling quadratic covariates
as linear, and excluding interactions terms from the model. Finally, a dataset from the shock
research unit at the University of Southern California is used to illustrate the estimation of the
adjusted AUC using the proposed approaches.
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CHAPTER 1: INTRODUCTION
In epidemiologic research, investigators are often interested in comparing a group of
people with a specific exposure to a similar group of people without that specific exposure
before disease appearance or other health outcomes. This objective is easily achieved in
experimental studies where the assignment to the exposure is controlled by the investigator and
is done in a random fashion. More generally, the exposure group could also be treatment or nontreatment groups, populations with the risk factor or not-with the risk factor, diseased or nondiseased populations, or some other binary indicator of a clinical state. However, experimental
studies are not always feasible for ethical, practical or financial reasons. For instance, in a study
comparing men and women in terms of health results, gender is the exposure of interest and it is
clearly impossible to randomly assign subject to different gender groups. Hence, the subjects
assigned themselves to one of the exposure groups in a non-random manner; this is referred to as
an observational study.
There has been an increased interest in observational studies to evaluate association
between exposure (risk factors of outcome) and outcomes. Because assignments to exposure are
not random in observational studies, any comparisons of outcomes between exposed and nonexposed subjects must account for factors related to the exposure of interest. This is important
because failing to adjust for the confounding variables could lead to biased estimates of true
effects. As a result, researchers using observational data are required to use advanced statistical
methods to control for bias and confounding.
Propensity score methods have been used for a long time to reduce bias in observational
studies (Rosenbaum & Rubin, 1984) . The main goal of the propensity scores is to balance
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observed covariates between two groups in nonrandomized trials so that the two groups are
comparable in the sense that their baseline covariates are expected to have similar distribution.
The most common ways of using propensity score to reduce confounding are: stratification on
the propensity score, matching on the propensity score and covariate adjustment on the
propensity score (Austin, 2008; Austin, 2010; Rosenbaum & Rubin, 1983) However, a common
concern in the development of propensity scores models, is the choice of variables to include in
the model. So far, there is no agreed upon ‘correct’ propensity score model among researchers.
In his seminal work on propensity scores, Peter Austin had investigated the performance
of propensity scores methods to estimate relative risk, odds ratio, hazard ratio, marginal odds
ratio, marginal hazard risk and difference in means (Austin, 2007a; Austin, 2008; Austin, 2010,
2013; Austin, Grootendorst, Normand, & Anderson, 2007). However, there is no mention in the
literature of the performance of propensity score when association is quantified by the area under
the receiver operating characteristic (ROC) curve.
In clinical research with continuous outcomes, the area under the ROC curve (AUC) has
gained an interest to assess treatment effects (Acion, Peterson, Temple, & Arndt, 2006;
Brumback, Pepe, & Alonzo, 2006; Hauck, Hyslop, & Anderson, 2000). The AUC can be
interpreted as the probability that a randomly selected participant in the exposed group has a
larger response (or greater suspicion in terms of continuous outcome) than a randomly selected
participant in the non-exposed group. For example, in a clinical study of whether or not obesity
is a risk factor for hypertension, an AUC of 0.76 may imply that a randomly selected patient
from the obese group (exposed group) has 76% chance of, say, a more suspicious (higher) blood
pressure than a randomly selected patient from the non-obese (non-exposed) group. Here, higher
values of blood pressure indicate hypertension.
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This dissertation research has two major parts. In the first part, we proposed the
propensity score methodology to control for confounding when association between exposure
and outcomes is quantified by area under the ROC curve. Additionally, we sought to determine
the optimal choice of variables to include in the propensity score model. Choices include
covariates related to risk group, covariates related to outcome, covariates related to both risk
group and outcome, and all measured covariates. We also compared the performance of the
propensity score approach to control for confounding to that of a conventional regression
approach to adjust for AUC. In the second part of this research, we examined the impact of
model misspecification in AUC regression adjusting for covariates by incorrectly modelling the
covariates in the data. These modelling errors include omitting covariates, dichotomizing
continuous variables, modelling quadratic covariates as linear, and excluding interactions terms
from the model.
This research is organized as follows. Chapter 2 contains a thorough review of literature
on propensity score methods, issues of variable selection in propensity score models, the area
under the ROC curve as a measure of association, methods to adjust for covariates and model
misspecification issues in AUC regression analysis. Chapter 3 addresses the first part of the
dissertation through a simulation study. In Chapter 4, the issue of model misspecification when
estimating the AUC adjusting for covariates is investigated through a simulation study. In
Chapter 5, the proposed approaches are applied to data from the Shock Research Unit at the
University of Southern California, Los Angeles, California. Chapter 6 is a concluding chapter
which summarizes the results of the simulations studies, addresses limitations and suggests
future study. Appendices cover SAS codes to estimate the AUC controlling for confounding and
validation of the simulated data along with balance diagnostics.
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CHAPTER 2: BACKGROUND & REVIEW
2.1
2.1.1

Introduction to propensity score

Definition of the propensity score

In cohort studies, failing to adjust for confounding variables could lead to biased estimates of
risk effect. In 1983, Rosenbaum and Rubin introduced the concept of propensity scores as a tool
to reduce bias in observational studies. In randomized experiments, subjects are assigned
randomly to treatment or control groups so that the two groups are comparable in the sense that
the distribution of their baseline covariates are expected to be the same. However, in
nonrandomized trials, the absence of random assignment doesn’t guarantee a similarity in the
distributions of the covariates between two groups; thus, direct comparisons may be misleading.
The goal of the propensity scores, then, is to balance observed covariates between two groups in
nonrandomized trials. Rosenbaum and Rubin defined the propensity score as the conditional
probability of assignment to a particular group given a vector of observed covariates
(Rosenbaum & Rubin, 1984). For instance, suppose each subject in the cohort has a vector of
observed covariates X , and an indicator of risk status Z such that Z  1 if subject has the risk
factor and Z  0 if subject has no-risk factor. Then the propensity score, e  x   Pr  Z  1| X  is
the probability that a subject with covariates X is in the risk factor group.
In a randomized trial, Pr  Z  1| X   Pr  Z  0 | X  i.e. subjects have the same chance to
be assigned to treatment or control using a randomization mechanism. In this manner, the
propensity score e  x   1 2 for every X . On the other hand, in an observational study, some
subjects are more likely than others to have the risk factor or to not have the risk factor at all, so
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their propensity scores could be either e  x   1 2 or e  x   1 2 . This is mostly due to the nonexistence of random assignment in observational studies. For example, suppose the risk factor of
interest is obesity and the outcome is high blood pressure, in a study. Some subjects who are
physically inactive are more likely to be in the risk group than subjects who are physically
active, hence their propensity score is e  x   1 2 . Another example is diabetes as a risk factor
and cardiovascular disease as outcome. Subjects with no history of diabetes in the family would
more likely fall in the non-risk group more often than people with a family history of diabetes;
hence subjects with no family history of diabetes have a smaller probability to be in the risk
group; so their propensity score would be e  x   1 2 . Now, two subjects with the same
propensity score, say e  x   0.75 are compared. Although, these subjects may differ in terms of
their respective covariates X but the good thing is that both subjects have the same chance of
being assigned to the risk group. Hence, this suggests that in the absence of random assignment,
if subjects in the risk factor and non-risk factor groups are grouped or matched based on the
same propensity scores, then the subjects in each group are expected to have similar covariates
distributions. Therefore, the propensity score is an instrument that balances observed covariates
between two risk groups in order to create the same probability structures as that achieved by a
“randomized” experiment.

2.1.2

Estimating propensity scores

Several approaches exist to estimate a propensity score such as the classification tree technique
using the recursive portioning and the neural networks methods (Setoguchi, Schneeweiss,
Brookhart, Glynn, & Cook, 2008; Stone, Obrosky, Singer, Kapoor, & Fine, 1995) , discriminant
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analysis (D'Agostino, 1998; Rosenbaum & Rubin, 1984), and the generalized additive models
(Woo, Reite, & Karr, 2008). However, logistic regression is used far more often than any of the
above mentioned methods. Logistic regression models the probability of having the risk factor as
a function of a set of the observed covariates X . The propensity score is then computed as the
expected probability of being in the risk group, conditional on X . The choice of covariates to be
included in the propensity score model is addressed in more detail in Section 2.2.

2.1.3

Propensity score methods to estimate risk effect

Once the propensity score has been estimated, it is used as a variable in an analysis to control for
confounding when estimating risk effect. The most common propensity score analysis methods
include stratification, matching, and covariate adjustment on the propensity score (Austin,
Grootendorst, & Anderson, 2007).
The basic idea of stratifying on the propensity score is to group subjects usually into five
approximately equal-size groups determined by the quintiles of the estimated propensity score.
These groups are considered to be homogeneous as subjects in each group are expected to have
similar propensity scores. The use of five strata is common because researchers have shown that
five groups can remove over 90% of the bias due to each baseline covariate (Cochran, 1968;
Rosenbaum & Rubin, 1984). The risk effect is then estimated within each stratum. The overall
estimated risk effect for the outcome will be a weighted average of the five stratum-specific risk
effects. The propensity score in stratification is very useful in adjusting for baseline differences
because outcome responses from the two risk groups are compared within subjects with similar
propensity score. Therefore, with stratifying on the propensity score, we expect to compare
individuals in risk and no-risk factor groups with similar distributions of baseline covariates X .
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In propensity score matching, the idea is to create matched pairs of risk factor and nonrisk factor subjects with similar propensity scores. In the literature, the most commonly used
matching method is the so-called greedy matching. As noted in Rosenbaum & Rubin (1984), the
greedy matching includes the: a) nearest available matching on the estimated propensity score; b)
Mahalanobis metric matching including the propensity score; and c) nearest available
Mahalanobis metric matching within calipers defined by the propensity score. These methods
have been meticulously defined elsewhere (D'Agostino, 1998; Rosenbaum & Rubin, 1985), and,
therefore, they are not shown here. According to Rosenbaum the third method i.e. the greedy
matching using calipers of a specified width produces the best balance between the covariates in
the two risk groups (Rosenbaum, 1995). This method consists of finding a match for a randomly
selected subject in the risk group by selecting the closest subject in the non-risk group within a
fixed distance i.e. the predetermined caliper of the propensity score. If there are several
candidates as potential match for the risk subject, then one is selected at random. If there are no
candidates, for instance if no subject in the non-risk group has a propensity score close to that of
the risk group subject, then the subject in the risk group is not included in the final matched
sample. The process is then repeated and once the risk subject has been matched to a non-risk
subject, then the latter is no longer available for consideration as a match for subsequent subjects
in the risk group; this is referred to as one-to-one (1-1) matching or matching without
replacement.
In the literature, users of greedy matching have matched risk groups subjects using
calipers of width ranging from 0.005 to 0.01 on the propensity score scale (Austin, 2009a).
However, from the results of a simulation study, Austin recommended using calipers of width
0.2 of the standard deviation of the logit of the propensity score or of width 0.02 or 0.03 on the
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propensity score scale, as they tend to have superior performance compared with other methods
that are used in the medical literature (Austin, 2007b, 2009a).
Other methods of matching include matching with replacement where the selected
subject in the non-risk group can serve as a match for more than one subject in the risk group.
However, this method has not been discussed much in the literature. Another alternative to the
greedy matching is optimal matching as described by Rosenbaum in his book Observational
Studies. This method consists of minimizing the total difference between the propensity scores of
the risk and non-risk subjects. This method can be computationally involved and is rarely use in
epidemiologic studies (Rosenbaum, 1995).
The propensity score covariate adjustment method, also referred to as regression
(covariance) adjustment was described by Rosenbaum & Rubin (1983) in their early work. In
this method, the outcome is regressed on two independent variables: an indicator variable Z
denoting the risk status group and the estimated propensity score. The estimated risk effect is
obtained from the regression coefficient for risk status. In a systematic review conducted by
Weitzen et al. (2004), they have shown that over half of the selected studies used the covariate
adjustment method. In these studies, the propensity score is used as either a single variable in the
regression model or with additional variables in a multivariable model. In other cases, the
propensity score was used as a categorical variable by dividing the propensity score into quintiles
to create categories (Weitzen, Lapane, Toledano, Hume, & Mor, 2004).
Regardless of the propensity score analysis method used, the focus should be to create
balance on all patients’ characteristics before comparing response outcomes for patients with the
risk factor and without the factor. Therefore, the estimated propensity score should be assessed

9
on its performance in creating balance before carrying out any outcome analysis as described in
Section 2.1.4.

2.1.4

Balance diagnostics for the propensity scores

Once the strata and the matched sample based on the propensity score have been constructed, it
is of great importance to check whether balance is achieved in measured baseline covariates
between risk factor and non-risk factor subjects. Methods to assess balance of each covariate
after propensity score adjustment include: i) measuring the standardized differences where it has
been suggested that a standardized difference greater than 0.1 is considered as an important
difference in the mean or prevalence of a covariate between risk factor groups (Austin &
Mamdani, 2006; Normand et al., 2001); ii) assessing the distribution of the propensity scores via
box plots: If the distributions of the propensity scores for risk and non-risk groups within each
quintile are similar, then a good balance is achieved. Furthermore, one should assess the overall
distribution of the propensity scores within each risk group (via box plots or histograms), and if
they overlap then the two groups are comparable in the sense of covariates; iii) finally, one could
report t-tests of equality of means between the two risk groups in regard to each continuous
covariate and a chi-square test for the dichotomous covariates within each quintile to show
similarity of the distribution of measured baseline covariates after propensity score adjustment.
To compare baseline characteristics between exposure groups, the standardized differences have
been suggested to be better than doing statistical tests as the former are independent of sample
size and estimates how many standard deviations the two groups differ by (Austin, 2009c). If
balance is not satisfied researchers recommend modification of the propensity score model by
deleting or adding covariates or even by considering a more complex model that includes
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interactions or nonlinear terms. This being said, in Section 2.2, we investigate the issues of
variable selection in the propensity score models.

2.2

Issues of variables selection in propensity score models

In the literature, a common concern in developing a propensity score model is to choose
which variables to include in the model. Little is known about the problem of variable selection
for propensity score models (Brookhart et al., 2006). In a propensity score model, the indicator
of risk status is treated as a dependent variable whereas the observed covariates are considered to
be the predictors. Based on their association with the risk group and the outcome, one can
categorize the observed covariates into four groups: 1) baseline covariates related to risk group;
2) baseline covariates related to the outcome; 3) baseline covariates related to both risk group
and outcome; these are referred to as true confounders; 4) and finally, all measured baseline
covariates (Austin, 2007a; Austin, 2008; Austin & Mamdani, 2006).
While there is no agreed upon method for determining the ‘correct’ propensity score
model, Weitzen et al. suggest using an algorithmic method such as backward elimination,
forward selection or stepwise selection for inclusion criteria (Weitzen et al., 2004). However,
Monte Carlo simulations studies have shown that a propensity score model with only covariates
associated with outcome or the true confounders resulted in a larger number of matched pairs,
thus, resulting in a smaller bias in the estimated risk effect (Austin, 2007a) and a smaller mean
squared error (Brookhart et al., 2006). These findings are consistent with the recommendations
of Rubin and Thomas that a variable related to the outcome should be included in the propensity
score model even if it is not statistically significant (Rubin & Thomas, 1996). The simulations
studies also noted that matching on models that contain baseline covariates related to risk group

11
only or all measured covariates, resulted in a lower number of matched pairs (Austin, 2007b) and
increased the variance of the estimated risk effect without decreasing bias (Brookhart et al.,
2006). Also, D’Agostino & D’Agostino recommend “fitting a model… that includes a subset of
patient characteristics that are thought to be the most important known potential confounders”.
The rationale behind this is to add precision to the effect estimate and adjust for any residual
imbalances that may exist after the propensity score modelling (D'Agostino & D'Agostino,
2007).
It is also important to note that the findings for the choice of variables described above
resulted from methods where investigators looked at outcome measures such as difference in
means or proportions, odds ratios, relative risk, or hazard ratios.
Regardless of the recommendations to select the ‘best’ propensity score model, users of the
propensity score analysis method seem to agree that the best model is based on whether balance
is achieved on all baseline covariates in order to correctly estimate risk effect between patients
with risk factor and non-risk factor.

2.3
2.3.1

Area under the ROC Curve as Measure of Association

P(X > Y) in clinical trials

For normal continuous outcomes, the mean difference between two populations is a well-known
measure of treatment effect. However, there is an increasing interest in the literature about the
use of the probability that a randomly selected participant in the treatment group  X  has a
better response than a randomly selected participant in the placebo group Y  , i.e. P  X  Y  . The
use of P  X  Y  as a measure of the effect in clinical trials has been introduced by Hauck et al.
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(Hauck et al., 2000) following a work by O’Brien (1988) in considering P  X  Y  to assess
treatment effects after noting that standard tests may fail to identify important treatment
differences. Hauck et al. (2000) believe that P  X  Y  is more understandable for the evaluation
of treatment comparisons. They also feel that it doesn’t make sense to restrict statistical
approaches to the simple difference of means between two populations because these two
populations might have different variations. For instance, a new treatment may have effects on
the distribution of responses other than on the average response. Therefore, if there is an
increased variability due to the effect of the new treatment, then the estimated effect is attenuated
when P  X  Y  is used as measure of treatment effect.
Acion et al. have also shown that P  X  Y  is clinically more meaningful than the change
in means which represents the magnitude of the mean difference but does not tell patients their
chance to improve under the new treatment. They described P  X  Y  as a “measure that
presents good qualities of meaning, simplicity, and robustness” (Acion et al., 2006).
As noted in Tian (2008), there are a few advantages of using P  X  Y  to assess treatment
effects over the change in means. First, it is scale-free, making P  X  Y  a reasonable measure
of treatment effect no matter how much variability exists between the two populations’
responses. Second, she showed that P  X  Y  does not change under monotonic transformation.
Hence, the theory developed for the original distribution are also valid for transformed
distributions (Tian, 2008).
Furthermore, the mean difference does not account for variability within the groups being
compared. Even if the standardized mean difference is used to overcome this problem, it is
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difficult for clinicians to interpret practically the improvement measured in standard deviations
units (Nunney, Clark, & Shepstone, 2013).
It is important to note that the probability P  X  Y  is equivalent to the area under the
curve (AUC) in methods for receiver operating characteristic (ROC) analysis.

2.3.2

P(X > Y) in ROC Analysis

The receiver operating characteristic (ROC) curve was originally developed for signal detection
theory by Green and Swets in 1966 (Green & Swets, 1966). Since 1982, however, the ROC
curves have been extensively used in the medical diagnostic testing as a powerful tool to assess
how well a diagnostic test can discriminate diseased and non-diseased populations. The ROC
curve is a plot of sensitivity vs 1-specificity. In general, the ROC curve describes the separation
between the distribution of the continuous outcome in two different populations (Brumback et
al., 2006). The ROC curve lies in the unit square, in which the diagonal line from vertices (0, 0)
to (1, 1) indicates no effect i.e. the distribution of response in the disease group is the same as
that of the response in the non-disease group. When the curve is pulled closer toward (0, 1) it
indicates better separation of the distributions of the responses in each group. The area under the
ROC curve (AUC) is an index used to summarize the accuracy of the diagnostic test. One
interpretation for AUC is the probability that for a randomly selected pair of diseased and nondiseased individuals, the diagnostic test value is higher for the diseased person (Pepe, 2003).
In this dissertation research, the measure of risk effect we suggest is the probability that a
randomly selected participant in the risk group has a larger response than a randomly selected
participant in the non-risk group. We assume without loss of generality that larger response
values are associated with the risk population, and smaller values with the non-risk population.
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More generally, the risk groups could also be diseased or non-diseased populations, treatment or
non-treatment (or placebo or standard treatment) groups, or some other binary indicator of a
clinical state. We restrict our research to the comparison of two groups: one of subjects with the
risk factor and the other of subjects without the risk factor. Let YRF and YNRF be two continuous
responses from the risk and non-risk group, respectively. In ROC analysis, the area under the
ROC curve (AUC) has a direct relationship with P YRF  YNRF  . If there is no risk effect i.e.
when the distribution of YRF is equal to the distribution of YNRF , then the AUC would be 0.50, that
is P YRF  YNRF   0.5 . This probability moves toward 1 as the risk group shows a higher
response.
2.4
2.4.1

Methods for estimating AUC

Correspondence of AUC with Mann-Whitney U

Let YRF , (i  1,..., n) and YNRFj , ( j  1,..., m) represent two continuous responses from random
i

variables YRF and YNRF representing n subjects in the risk group and m subjects in the non-risk
m

n



group, respectively. The Mann-Whitney U statistic is defined by: U   I YRFi  YNRFj
i 1 j 1





mn



where I YRFi  YNRF j is an indicator function of the number of concordant pairs in which





I YRFi  YNRF j  1 if YRFi  YNRFj , and 0 otherwise.

The detail of the proof of the equivalence between the Mann-Whitney statistic U and
AUC is shown in (Pepe, 2003). However, a brief summary of this correspondence is based on the
observation that AUC  P YRF  YNRF  . This is evident from the ROC curve that plots
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I YRF  c 
n

j 1

n

versus



YNRF

 c

m

i 1

i.e. the estimation of the P YRF  c  versus P YNRF  c 

where c represents some threshold such that a participant is classified as having the risk factor
when their response is greater than c.
Sometimes, the responses YRF and YNRF are related to baselines covariates. Hence, in order
to accurately compare the two outcomes, adjustment for these covariates should be made.

2.4.2

Correspondence of AUC with placement values

Delong et al. introduces the idea of placement values (DeLong, DeLong, & Clarke-Pearson,
1988). The goal of the placement values is to use the distribution of the responses in the non-risk
population as the reference (or control) distribution for standardizing the responses in the risk
population. For instance, suppose YRF and YNRFj denote responses for a sample of n subjects in
i

the risk group and m subjects in the non-risk group, respectively. According to the Delong
Method, for a response YRF for a subject i in the risk group, its “placement value”, called
i

 

Vi YRFi , is the fraction or percentage of the responses YNRFj in the non-risk group that it exceeds.

Hence, its placement value formula is given by:

 

Vi YRFi 





1 m
 YRFi , YNRFj
m j 1



 i  1, 2,..., n 



where  YRFi , YNRF j is an indicator variable indicating the ordering of the responses such that





 YRF , YNRF  1 if YRF  YNRF , 0 if YRF  YNRF , and 0.5 if YRF  YNRF .
i

j

i

j

i

j

i

j
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Similarly, if the distribution of the responses in the risk population is set as the reference







 j  1, 2,..., m 

distribution, the placement value, V j YNRF j , for a subject j in the non-risk group is given by:





V j YNRF j 





1 n
 YRFi , YNRFj
n i 1



Where  YRFi , YNRF j  1 if YNRFj  YRFi , 0 if YNRFj  YRFi , and 0.5 if YRFi  YNRFj .
The placement value concept is a familiar way of standardizing the outcome relative to
the reference population distribution. For example, if a child’s weight corresponds to the 75th
percentile in a healthy population then its equivalent placement value is 25% (Pepe, 2003).
Pepe et al. have also extended the Delong Method to show that the set of placement values

V Y  ,V Y  can be used to plot the ROC curve (Pepe & Cai, 2004; Pepe & Longton,
i

RFi

j

NRF j

2005). The area under the ROC curve (AUC) is obtained by averaging the placement values:



 



AUC  mean of Vi YRFi  mean of V j YNRF j .

2.5

AUC controlling for covariates

In the literature, there exist some works describing how to accommodate for covariates
for AUC. Recall in the context of this research, we set AUC  P YRF  YNRF  where
YRF and YNRF are continuous responses from a risk-group and a non-risk group, respectively.

In context for the reliability of the stress-strength system, early work introduced by
Reiser et al. has examined statistical inference for P Y1  Y2  , where Y1 and Y2 are independent
normal variates with unknown means and variances. In their model, Reiser and Guttman
considered Y1 as the strength and Y2 as the stress where the stress is applied to the strength of a
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component. As such, P Y1  Y2  measures the reliability (Reiser & Guttman, 1986). In the same
context of stress-strength models, Guttman et al. (1988) estimated P Y1  Y2  adjusting for
covariates through linear regression models with the following assumptions: Y1 and Y2 are
normally distributed, Y1 and Y2 depend (linearly) on the covariates to adjust for, and there exists
an equal variance between strength ( Y1 ) and stress ( Y2 ) (Guttman, Johnson, Bhattacharyya, &
Reiser, 1988).
In 2003, Faraggi extended Guttman et al.’s method to examine covariate effects on AUC,
assuming a parametric distribution (Faraggi, 2003). His method is based on using regression
modelling to model the covariates effects on the outcomes to obtain AUC depend on covariates.
Other work to accommodate for covariates for AUC was based on nonparametric and
semiparametric theories developed by Margaret Sullivan Pepe. For continuous diagnostic tests,
Pepe proposed three methods based on regression analysis techniques to control for possible
effects of covariates on ROC curves (Pepe, 1998).. Her second approach which is relevant to
estimating AUC while adjusting for covariates consisted of estimating AUC nonparametrically
using the Wilcoxon statistic. In this approach, the AUC for each covariate with level k was
estimated by ˆk . Then, the expected value of ˆk was modelled as a linear function of the

 

covariates X , which, at level k, are denoted by X k such that E ˆk  b0  b1 X k . This method
may be computationally involved and complex.
Brumback et al. developed a more general approach to accommodate for covariates for
the non-parametric treatment effect, P YRF  YNRF  . Their method mainly consists of adjusting
for a discrete covariate X . Their technique can be described as follows:
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1) Each level of the discrete covariate X is considered as a stratum s such as s  1,..., S ,
where S represents the total number of strata;
2) Within each stratum s , they compute all of the 0 or 1 indicator data such that





I YRFi  YNRF j  1 if YRFi  YNRF j , and 0 otherwise;

3) The adjusted AUC is the sum of all the indicator function of the the number of





concordant pairs, i.e. I YRFi  YNRF j within each strata divided by the sum of the product of the
number of subjects in the risk factor group and non-risk factor group in stratum s . Hence, the
S

ns

ms





S

adjusted estimator is given by AUC adj   I YRFi  YNRFj / N where N   n s m s , and n s
s 1 i 1 j 1

s 1

and m s are the number of subjects in the risk factor and non-risk factor group in stratum s,
respectively (Brumback et al., 2006). The caveat of this method is that it only accomodates a
single discrete covariate.
Janes et al. proposed a covariate-adjusted measure of classification accuracy called the
covariate-adjusted ROC curve, or AROC for accomodating for covariates in ROC analysis. The
AROC is a weighted average of covariate-specific ROC curves. The deriving summary indice is
the area under the covariate-adjusted ROC curve, AAUC which is interpreted as the probability
that, for a random case and control marker observation with the same covariate value, the case
observation is higher than the control. Their AAUC can be estimated empirically or a parametric
distribution can also be assumed (Janes, Longton, & Pepe, 2009) .
In this research, we applied Janes et al.’s approach in the context of epidemiologic
research to compare two risk groups while controlling for confounding and where the risk effect
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is quantified by the probability that a randomly selected participant in the risk group has a larger
response than a randomly selected participant in the non-risk group, P YRF  YNRF  .
Janes et al.’s approach in estimating the AUC controlling for confounding is based on the
concept of placement values (PV). For instance, let YRF and YNRF be two continuous normal
responses arising from a risk factor population and a non-risk factor population, respectively.
The indicator variable T denotes the populations such that T  1 if the subject has the risk factor
and T  0 if the subject is without the risk factor. Let Z denotes a vector of covariates for each
subject. Let us consider the population where T = 0, as the reference or control group and use the
subscript NRF (Non-Risk Factor) for index-related quantities. According to Jane et al.’s
method, the covariate adjusted AUC is computed following two major steps. The first consists of
estimating the cumulative distribution (CDF) for the response YNRF in the control group as a
function of Z (i.e. the vector of covariates of interest requiring adjustment). This is done by
specifying a linear model YNRF   0  Zβ1   in which the error term is normally distributed and
the covariates act linearly on the distribution of YNRF . Then for each subject i in the risk factor
group, we compute the placement values. The placement value is the standard normal CDF of

Y

RF





  where  ,  , and 

  0  Z β1 /  , hence PV RF , Z   YRF   0  Z β1 / 

0

1

are the

regression coefficients estimates and the standard deviation of the linear model of control
observations, respectively. The second major step is to estimate the adjusted AUC which is the
nRF

mean of the estimated placement values: AUC   PV RF ,Z / nRF where n RF is the number of case
i 1

observations. The algorithm for estimating the adjusted AUC under a parametric assumption is
summarized in the following table:
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Step
1

2

3

Procedure Description

Model

Estimate the cumulative
distribution of Y in the control
group as a function of Z :

Assumption


YNRF   0  Zβ1  

Calculate the placement values for
each subject in the risk factor
group.



 

PV RF , Z   YRF   0  Z β1 / 

Estimate AUC by computing the
mean of the estimated placement
values.

AUC 

nRF

 PV
i 1

RF , Z

/ nRF



N 0,  2



 0 , 1 and  are the regression
coefficients estimate, and the
standard deviation, respectively of
the control observations.  is the
Standard normal CDF.
n RF is the number of case

observations.

The standard errors for the estimated AUC are obtained by bootstrapping the data. The
data is resampled separately within risk and non-risk strata. The algorithm for computing the
adjusted covariate AUC has been incorporated into STATA under the comproc command
developed by Janes et al. We developed a similar algorithm in SAS called the %aAUC macro to
estimate the adjusted AUC-See Appendix.

2.6

Model Misspecification

Several parametric, semiparametric and nonparametric methods have been proposed in
estimating AUC adjusting for covariates (Brumback et al., 2006; Faraggi, 2003; Janes et al.,
2009; Pepe, 1998). However, little is known about the impact of model misspecification when
estimating the AUC that accommodates for covariates. Walsh (1997) investigates the robustness
of the binormal assumption by specifically investigating bias associated with the estimates of
AUC if the binormal assumption was violated (Walsh, 1997). In the context of stress-strength
model, Greco and Ventura in a recent work recognized that model assumptions can badly affect
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the estimated AUC, and propose a robust inferential procedure to address this issue (Greco &
Ventura, 2011). However, none of these methods mention model misspecification in the
presence of covariates.
In 1988, Lagakos investigated the effects of misspecification in linear models for measured
response variables. He examined the particular case of mismodelling or discretizing a continuous
variable (Lagakos, 1988) . Furthermore, in 1990, Begg and Lagakos have considered the
consequences of model misspecification when the model contains misspecified forms for both
exposure and covariates (Begg & Lagakos, 1990). They found that omitting a needed variable
lead to a seriously biased estimates of treatment effect.
Failing to correctly model the covariates could lead to biased estimates of treatment
difference in outcome. To our knowledge, no research has been carried out to investigate the
effect of covariates misspecification in estimating the adjusted AUC. In this research, we use the
term “misspecification” to investigate a wide range of modelling errors and its impact on the
estimated AUC. These modelling errors include omitting covariates, dichotomizing continuous
variables, modelling quadratic covariates as linear, and excluding interactions terms from the
model. The performance of the estimated AUC is examined based on bias, relative bias, mean
squared error and coverage of 95 per cent confidence intervals.
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CHAPTER 3: PROPENSITY SCORE
In this chapter, we examine the performance of propensity score methods to control for
confounding when AUC is used to quantify association. We estimated several adjusted AUC using
different propensity score-based methods as presented in Section 2.1.3. As a secondary objective,
we sought to determine the optimal choice of variables for the propensity score model. This choice
includes covariates related to risk group, covariates related to the outcome, covariates related to
both risk group and outcome, and all measured variables. A simulation study was conducted to
evaluate and compare the propensity score methods and models.

Design of Simulation Study
Data were simulated using a framework similar to those used by Austin et al. to examine
the performance of different propensity score methods and models for estimating treatment effects
(Austin, 2008; P. C. Austin et al., 2007). Data are generated according to the following steps:
Step 1: Eighteen baseline covariates were randomly generated such that nine of them
were dichotomous and the other nine were continuous. Each of the 18 variables varied in their
association with the risk factor group and the outcome as described in the following table:
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Table 3.1 Association between baseline covariates with risk group and outcome.
Strongly associated
Moderately associated
Not associated with
with risk group
with risk group
risk group
Strongly
associated with
outcome

b1 , c1

b2 , c2

b3 , c3

Moderately
associated with
outcome

b4 , c4

b5 , c5

b6 , c6

Not associated
with outcome

b7 , c7

b8 , c8

b9 , c9

The 12 variables b1 , c1 , b2 , c2 , b4 , c4 , b5 , c5 , b7 , c7 , and b8 , c8 are related to the risk group, while
the 12 variables b1 , c1 , b2 , c2 , b3 , c3 , b4 , c4 , b5 , c5 , and b6 , c6 are related to the outcome. The 8 variables
b1 , c1 , b2 , c2 , b4 , c4 , and b5 , c5 are related to both risk group the outcome and are thus confounders.

The two variables b9 , c9 are neither associated with the risk group nor with the outcome.
The association between a given variable and risk group was measured by the odds ratio.
A moderate or a strong association was assumed if the presence of the given variable in the logit
model increases the odds of being in the risk group by a factor of 1.5 or 2, respectively (Austin,
2009b; Monson, 1990). A moderate or a strong association was defined as the odds of having the
risk factor is increased by a factor of 1.5 or 2 for binary covariates, respectively (Austin, 2009b)
and 1.5 and 1.25 for continuous covariates (Austin, 2010).
Similarly, the association between outcome and a binary variable is measured with the
point-biserial correlation; the association between outcome and a continuous variable is
measured with the Pearson correlation. The point biserial correlation is a measure of association
between a continuous variable and a binary variable. It is a special case of the Pearson
correlation. The strength of the association between a given variable and an outcome is measured
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with a correlation of 0.5 and 0.3 to reflect a strong and a moderate association, respectively.
Cohen in 1988 , proposed these guidelines for interpreting the magnitude of correlation
coefficients (Cohen, 1988). Such correlations are not unusual in epidemiologic research. For
example, in a study of association between cardiovascular death rates and municipal drinking
water, Schroeder (1966) reported a correlation between death rates from arteriosclerotic heart
disease and hardness of municipal waters of -0.50 (P<0.0005) in males and of -0.36 (p<0.005) in
females (Schroeder, 1966). Another study from the child and adolescent trial for cardiovascular
health (Osganian et al., 1999) also showed correlations of magnitude similar to those considered
here. For example, the study has found a strong correlation between folic acid and vitamin B6 (r
=0.48; P =0.001) and “somewhat stronger” correlation between serum homocysteine and folic
acid (r= -0.36; P=0.001).
Hence, for this simulation study, we considered correlations values of 0.5, 0.3 and 0 to
depict strong, moderate and no association, respectively between a given variable and the
outcome; and odd ratios values of 2, 1.5, and 1 for a strong, moderate, and no association
between a covariate and the risk factor group.
To determine the optimal choice of variables for the propensity score (PS) model, four
propensity score models were specified in the Monte Carlo simulation experiments:
PS-Model 1: This model includes all 12 variables associated with the risk factor group:
b1 , c1 , b2 , c2 , b4 , c4 , b5 , c5 , b7 , c7 , and b8 , c8 .

PS-Model 2: This model includes all 12 variables associated with the outcome:
b1 , c1 , b2 , c2 , b3 , c3 , b4 , c4 , b5 , c5 , and b6 , c6 .
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PS-Model 3: This model includes all 8 variables associated with both the risk factor group and
the outcome: b1 , c1 , b2 , c2 , b4 , c4 , and b5 , c5 .
PS-Model 4: This model includes all 18 generated variables: b1  b9 and c1  c9 .
Step 2: Next, we generated a risk factor status T for each subject. To do so, data were
simulated such that the logit of the probability of having the risk factor for the ith subject is
linearly related to the 12 covariates associated with the risk factor group. In other words, the
subject-specific probability of group assignment was determined assuming that the probability of





group assignment Pgroup was related to the 12 baseline covariates that are strongly and
moderately associated with the risk group i.e.  b1 , b2 , b4 , b5 , b7 , b8 , c1 , c2 , c4 , c5 , c7 , c8  through the
following logit model:
 Pgroup
logit  log 
 1 P
group



   0  1b1   2b2   4b4  5b5   7b7  8b8

 1c1   2c2   4c4   5c5   7 c7   8c8

(3.1)

Hence, the subject-specific probability of group assignment is obtained by inversing the logit:

Pgroup 

exp  logit 

(3.2)

1  exp  logit 

The risk factor status T for each of the N subjects was generated from a Bernoulli distribution





with a parameter Pgroup i.e. T

Bernoulli  Pgroup  . The risk factor status vector is computed by





comparing the estimated probability of group assignment Pgroup to a random variable U
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1 if U  Pgroup
generated from Uniform  0,1 . We assign T  
. T =1 if the subject has the risk
0 if U  Pgroup
factor and T=0 otherwise.
Step 3: In this last step of our data generating process, for each of the N subjects, a
continuous outcome Y conditional on risk factor status T was generated through the following
linear model:
Y   0   T  1*b1   2*b2  3*b3   4*b4  5*b5   6*b6

(3.3)

 1*c1   2*c2   3*c3   4*c4   5*c5   6*c6  

Each regression coefficient was estimated assuming the outcome Y and the single covariate X
(i.e. b1  b9 , c1  c9 ) were related through a regression equation:

Y   X 

(3.4)

where  is a regression parameter and  represents modelling error such that 
covariate X could be continuous, X

N (x ,  X2 ) , or dichotomous, X

N (  ,  2 ) The

Bernoulli ( p ) . The

following is a derivation of the formula used to estimate the regression coefficients in Equation
(3.3)
If X and Y are linearly related, then the Pearson product-moment correlation is estimated by



Cov(Y , X )
Var (Y )  Var ( X )

(3.5)

The formula for  is known to be related to the regression coefficient as:
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x
y

(3.6)

From equation (3.6), we derived the regression coefficient  such that

 

y
x

(3.7)

The formula for  can be written in terms of variances of X and  ,

 

 2 x2   2
x

(3.8)

where  y2  Var Y   Var   X      2Var  X   Var   = 2 x2   2
Solving (3.8) for  , each regression coefficient in equation (3.3) is determined by

 


x

1
1-  2 

(3.9)

where  x and   are the standard deviations of the covariate of interest and the error term,
respectively.
The effect on outcome of risk group compared to non-risk group is quantified by AUC
statistic through  T in Equation (3.3). Hence, the effect size is given by     * 2 1  AUC0 
that is  is a function of the true AUC which is denoted AUC0 . This formula can be derived as
follows:
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When outcomes are normally distributed in the risk factor  RF  and non-risk  NRF 
populations i.e. YRF

2
N  RF ,  RF
 , YNRF

2
N  NRF ,  NRF
 ,and 

N ( ,  2 ) , then the AUC for

the binormal ROC curve is:

a 
AUC   

2
 1 b 

where a 

(3.10)

 RF   NRF

, b  NRF ,  denotes the standard normal cumulative distribution
 RF
 RF

function (Pepe, 2003).
We assumed  NRF  0,  RF   NRF    . Hence, a 

 RF
and b  1 .


Thus, the true AUC can be expressed as
 

AUC0    RF 
  2 

(3.11)

Solving Equation (3-11) for  RF which we called  for simplicity, the effect size is given by

   RF    * 2 1  AUC0 

(3.12)

Simulating Data
A sample of size N = 500 was considered in this simulation study; for each of the N subjects,
we randomly generated:
1) 18 independent baseline covariates such that 9 of them are dichotomous variables from a
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Bernouilli distribution with parameter 0.5:  b1 , b2 , b4 , b5 , b7 , b8 , b9 

Bernouilli  0.5 and the other

9 are continuous from a standard normal distribution:  c1 , c2 , c4 , c5 , c7 , c8 , c9 

N  0,1 . Each of

the 18 covariates varies in their association with the risk group and the outcome as described in
Table 3.1.
2) A risk factor status for each of the N subjects by first generating the logit model in
Equation (3.1):
 Pgroup
logit  log 
 1 P
group



  1.65  log(2)b1  log(1.5)b2  log(2)b4  log(1.5)b5  log(2)b7  log(1.5)b8

 log(1.5)c1  log(1.25)c2  log(1.5)c4  log(1.25)c5  log(1.5)c7  log(1.25)c8

 0 is set to -1.65, so that approximately 50% of subjects would be exposed to the risk factor
group. This was determined in an initial set of Monte Carlo simulations. As described in section
3.1, we set  1 , 4 , 7   log(2) and 1 ,  4 ,  7   log(1.5) to depict a strong association between
the risk group with the binary and continuous covariates, respectively;  2 , 5 , 8   log(1.5) and

 2 , 5 , 8   log(1.25) to depict a moderate association between the risk group with the binary
and continuous variables, respectively. Next, we generated a risk factor status T according to the
methods described in Section 3.1 and Equation (3.2).
3) A continuous outcome conditional on the risk factor status T using Equation (3.3):

Y   T  4.6b1  4.6b2  4.6b3  2.6b4  2.6b5  2.6b6
 2.3c1  2.3c2  2.3c3  1.3c4  1.3c5  1.3c6  
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where 

N  0, 4  . The regression coefficients were determined using Equation (3.9) such that

the correlation value between  b1 , b2 , b3 , c1 , c2 , c3  and the outcome would be 0.5 for a strong
association and the correlation between  b4 , b5 , b6 , c4 , c5 , c6  and the outcome would be 0.3 for a
moderate association. We set  0  0 .  is a function of the true AUC as shown in Equation
(3.12). We considered three different values of AUC0 in the outcomes-generating process: 0.5,
0.7, and 0.9. These values were set according to the general rule of interpreting AUC suggested
by Hosmer and Lemeshow (Hosmer & Lemeshow, 2000). An AUC of 0.5 indicates no
association between outcome and exposure; an AUC of 0.7 indicates an acceptable association;
and an AUC of 0.9 indicates an excellent association between exposure and outcome. The AUC
values of 0.5, 0.7, and 0.9 are interpreted as follows: If we randomly select two subjects, one
with the risk factor and the other without the risk factor, the probability that the subject with the
risk factor has the condition is 0.5, 0.7, and 0.9 respectively. In other words, there is a 50-50, 7030 and 90-10 chance for a subject having the risk factor to develop the condition compared to a
subject not having the risk factor.
The data generating process described here was repeated 2500 times. All data generation and
analyses were completed using SAS version 9.3 and 9.4.

Estimating the propensity score
In this research, the propensity score is estimated using a logistic regression model where
the risk factor status T is regressed on measured baseline covariates. To determine the optimal
choice of variables for the propensity score model, we consider four categories of variables for
inclusion in the propensity score model: 1) variables related to risk group; 2) variables related to
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the outcome; 3) variables related to both risk group and outcome; and 4) all measured variables.
The logistic model depicting the conditional probability of assignment to a particular risk group
given a vector of observed covariates X i for the i th subject is given by:

Pr Ti  1| X i   e  xi  

e x i βi
1  e x i βi

(3.13)

Where Ti is the binary group assignment and Ti  1 if the subject belong to the risk factor group
and Ti  0 if the subject is in the non-risk factor group. βi is the vector of regression parameters.

Constructing strata and matched sets with the estimated propensity scores
In general, the estimates of propensity scores are used for sub-classification and in
matching to control for confounding in observational studies.
As described in Section 2.1.3, a step-by-step approach described by D’Agostino Jr.
(1998) and Perkins (2000) was used to create propensity score strata based on the quintiles of the
estimated propensity scores (D'Agostino, 1998; Perkins, Tu, Underhill, Zhou, & Murray, 2000).
Furthermore, matched pairs of risk factor and no- risk factor subjects with similar
propensity scores were formed. The 1:1 greedy matching technique using calipers of width 0.2 of
the standard deviation of the logit of the propensity score was used to form these pairs (P. C.
Austin et al., 2007; Austin & Mamdani, 2006). The %GMATCH macro in SAS obtained from
the Mayo Clinic website at http://www.mayo.edu/research/departments-divisions/departmenthealth-sciences-research/division-biomedical-statistics-informatics/software/locally-written-sasmacros was used to construct a SAS dataset containing the matched subjects.
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Estimation of risk effect
Risk effects were estimated via the AUC statistic using different propensity score
analysis methods as described in Chapter 2. We also used different propensity score models in
estimating AUC to explore how variable selection affects the estimate of the risk effect on the
outcome.

3.5.1 Unadjusted AUC
As described in Section 2.4.1 the unadjusted AUC is computed based on the fact that it is
equivalent to the two-sample Mann-Whitney U statistic (Brumback et al., 2006; Mann &
Whitney, 1947; Pepe, 2003) in the form:

 I Y
m

U

n

i 1 j 1

RFi

 YNRFj



mn
(3.14)

1, if YRFi  YNRFj
where I YRFi  YNRFj  
otherwise
 0,





YRFi , (i  1,..., n) and YNRFj , ( j  1,..., m) are two continuous responses from random variables

YRF and YNRF representing populations in the risk group and the non-risk group, respectively. The

variance of the unadjusted AUC is calculated based on a formula suggested by (DeLong et al.,
1988) which is incorporated into SAS via PROC LOGISTIC.
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3.5.2 AUC based on stratifying on the propensity score (The PS stratified AUC)
The adjusted AUC based on stratifying on the propensity score was obtained by extending the
method proposed by Brumback et al. (2006) as described in Section 2.5. Following their
technique, the adjusted AUC is given by:
S

AUC

adj

ns

ms





  I YRFi  YNRFj / N
s 1 i 1 j 1

(3.15)

S

where N   n s m s , and n s and m s are the number of subjects in the risk factor and non-risk
s 1

factor group in stratum s, respectively.
Our proposed method is based on Equation (3.15) where each strata is determined by the
quintiles of the estimated propensity scores; that is the 20th, 40th, 60th, 80th, and 100th percentile
of the total sample. It can readily be shown that the proposed adjusted AUC that we refered to as
the “Adjusted Propensity Score Stratified AUC” is a weighted average of the stratum-specific
AUCs, given by:
S

adj
AUC Stratified
  ws AUCS

(3.16)

s 1

Where ws 

ms ns

, m s and n s are are the number of subjects in the risk factor and non-risk

S

m n
s

s

s 1

factor group in stratum s, respectively. S  1, 2,3, 4,5 correspond to the quintiles of the
propensity score.
This can be readily seen as follows. Suppose YRF and YNRF are two continuous outcome
measures for m subjects in the risk factor  RF  group and n subjects in the non-risk  NRF 
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group. Let X be a discrete covariate corresponding to 5 stratas where each strata is determined
by the quintiles of the estimated propensity scores. From Equation (3.14), the unadjusted AUC is
given by:

AUC unadj  P YRF  YNRF  

1 m n
 I YRF  YNRF 
mn i 1 j 1

Hence, the stratum-specific AUC can be written as:
1
AUCS  s s
mn

ms

ns

 I Y

RF

i 1 j 1

 YNRF 

(3.17)

where ( s  1, 2,3, 4,5) and m s and n s represent the number of subjects in the risk factor and nonrisk factor group in stratum s, respectively.
From Equation (3.15), the adjusted AUC can be written as:
S

adj
AUC Stratified
  AUCS *
s 1

ms ns

(3.18)

S

m n
s

s

s 1

We observe that the adjusted AUC in Equation (3.18) is a weighted average of the stratumspecific AUCS . Thus, Equation (3.18) may be rewritten to obtain the Equation in (3.16):

S

adj
AUC Stratified
  ws AUCS where ws 
s 1

ms ns
S

m n
s

s

s 1

The variance of the adjusted propensity score stratified AUC is given by:
S

adj
    ws  Var  AUCS 
Var  AUC Stratified

 s 1

The variance equation is derived as follows.

2

(3.19)
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S
adj
  VAR   ws AUCS 
VAR  AUC Stratified




 s 1

S

  VAR  ws AUCS 
s 1
S

   ws  VAR  AUCS 
2

s 1

The AUCs standard errors are also obtained using Delong’s approach (1988) of estimating the
variance of the Mann-Whitney statistic which was incorporated in SAS PROC LOGISTIC
(DeLong et al., 1988).

3.5.3 AUC based on matching on the propensity score
We estimated the adjusted risk effect via AUC in the propensity score matched sample based on
Janes et al.’s method (2009) for accommodating covariates in ROC analysis as described in
Section 2.5. The estimated risk group effect is estimated in the matched sample as the mean of
the placement values (PVs) for each subject with propensity score PS in the risk group:
nRF

adj
AUCmatched
  PV RF , PS / nRF

(3.20)

i 1

where n RF is the number of subjects having the risk factor in the matched sample. The PVs of the
response YRF for each subject with estimated propensity score PS in the risk group is given by:



 

PVRF , PS   YRF   0  1 PS /  .  0 , 1 and  are the estimates of regression coefficients and

the root mean squared error, respectively, from the observations in the non-risk group. These
estimates were obtained through a regression model of the response YNRF in the non-risk group as
a function of the propensity score PS . The model is given by YNRF   0  1 PS   , where
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N 0,  2 . The variance estimates of the adjusted AUC were obtained via bootstrapping using

1000 bootstrap samples of the original observations.

3.5.4 AUC based on covariate adjustment using the propensity score
The adjusted risk group effect is estimated under the covariate adjustment method by regressing
the outcome variable on the estimated propensity score and the variable representing risk group
status T using the regression method developed by Janes et al (2009) described in Section 2.4.
The standard errors for the estimated AUC were obtained by bootstrapping the data.

3.5.5 AUC based on simple regression adjustment not using the propensity score
For comparison purposes we estimated AUC based on ROC regression method (Janes et al.,
2009). This method consists in directly modelling covariates effects on the response, within the
general context of regression. Hence, the outcome is modelled as a function of an indicator
variable denoting the risk group status and a set of independent covariates. We refer to this
method as the “direct AUC regression adjustment” method. We use the same four groupings of
covariates for inclusion in the regression model as were used in the propensity models: 1)
covariates related to risk group; 2) covariates related to the outcome; 3) covariates related to both
risk group and outcome; and 4) all measured covariates. The effect of the covariates on the
outcome is directly estimated by the AUC statistic using the concept of placement values as
described in Section 2.4.2.
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Evaluation criteria for estimated AUC
As evaluation criteria for the performance of the estimated AUC, we considered bias,
relative bias, variance estimation, mean squared error (MSE), and coverage of 95% confidence
interval across the 2,500 simulated data sets. In this section we review some of those criteria.

3.6.1 Bias and relative bias
An estimation of bias of the estimated adjusted AUC for a given propensity score model is the
mean estimated adjusted AUC of the 2,500 samples minus the true AUC that is used in the data
generating process. The relative bias provides a measure of the magnitude of the bias; it is
defined as the ratio of the estimator bias and its true value.
Bias  AUC  AUCtrue

(3.21)

 AUC  AUCtrue 
Relative Bias  100* 

AUCtrue



(3.22)

3.6.2 Mean squared error and root mean squared error
The mean squared error (MSE) of the estimator AUC is the average squared difference between
the estimator AUC and the true value of the risk effect AUCtrue . It incorporates both bias and
variance. The RMSE is the square root of the MSE. The more accurate estimator would lead to a
smaller MSE and RMSE.

2,500

MSE 

  AUC  AUC 
true

i 1

2,500

2

 Var  AUC    Bias 

2

(3.23)
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3.6.3 Coverage probability of 95% confidence interval
For each propensity score method and model, a coverage probability of the 95% CI is reported.
The coverage probability is the percentage of estimated 95% confidence intervals that contain
the true AUC. The intervals estimators were computed using the normal approximation interval
i.e. 95%CI   AUC  t0.975, n 1 s/ n , AUC  t0.975, n 1 s/ n  where the 1   / 2  quantile of the t
distribution is t1 / 2,n 1 with n  1degrees of freedom. Coverage was estimated by counting the
proportion of times out of 2500 that the estimated confidence interval included the true value.
We determined whether the coverage was significantly different from 0.95 by approximating the
distribution of the binomial probability p using the normal distribution with standard deviation

1
1
pˆ (1  pˆ ) . Therefore,
p(1  p) . Hence, the normal approximation interval is given by pˆ  z
n
n
based on the 2,500 simulated data, any coverage outside of 94.15%, 95.85% is statistically
different from 95%.

Results of the simulation study
Results of the simulation study are given in Tables 3.2 to 3.8 and in Figures 3.1 to 3.3.
The mean estimated risk effect across the 2,500 simulated data sets for each propensity sore
methods and each model we considered is given in Table 3.2. The crude estimate is biased
positively when the true risk group effect are 0.5 and 0.7 but is biased negatively when the true
AUC is 0.9.
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When stratification on the quintiles of the propensity score is used, we observe three
things: 1) the amount of bias is similar within each effect group regardless of the propensity
score model used; 2) the risk effect is overestimated when there is no effect (True AUC = 0.5)
and underestimated when the true effects are 0.7 and 0.9; 3) the risk estimate when truth is 0.7 is
associated with the least bias.
When matching on the propensity score is used, we noticed that when there is no effect,
the bias is almost null, but it is not the case when the true was 07 or 0.9. Also, the choice of
models did not matter, the risk estimates were similar across all models for each true AUC.
When covariate adjustment on the propensity score is used, the findings are similar to
those previous ones. When AUC is 0.5, the results are similar to those found with matching,
including the RMSE. However, PS model 2 i.e. model including variables associated with
outcome seems to have the least bias. These findings are not consistent across the true effects
and the amount of bias is still high.
From these results, it appears that stratifying, matching and covariate adjustment on the
propensity score resulted in biased estimation of AUC. When true effects were 0.7 and 0.9, the
estimated risks from all methods and models were negatively biased with relative biased ranging
from -15% to -7% as seen in Table 3.4. Prior research demonstrated that conditioning on the
propensity score resulted in biased estimation of odds ratio and hazard ratio (P. C. Austin et al.,
2007). So our results are not totally unexpected.
Finally, we investigated risks effects estimated from simple regression adjustment for
comparative purposes. The mean estimated risk effects perform better than those estimated from
the propensity score models. The second regression model including all covariates associated
with outcomes was found to be the best model in estimating the true effect. Similarly, the fourth
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model including all measured covariates resulted in unbiased estimates of the risk effect except
when true was 0.5. However, the first and third models which do not include all the variables
related to outcome resulted in biased estimates of the true AUC. Also, these models increased
MSE especially when true effects were 0.7 and 0.9.
In conclusion, if an investigator is interested in estimating AUC while controlling for
covariates, we recommend not to use the propensity score methods to adjust covariates; instead
the conventional AUC regression adjustment is the method to use. Furthermore, AUC regression
modeling adjusting for covariates related to the outcome and the model adjusting for all variables
lead to unbiased estimation of AUC.
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Table 3.2 AUC Estimates from different methods and different models
True AUC
Models/Methods

0.5

0.7

0.9

Unadjusted

0.6293

0.7302

0.8468

PS Stratify -M1

0.5502

0.6374

0.7900

PS Stratify -M2

0.5488

0.6493

0.8078

PS Stratify -M3

0.5511

0.6511

0.8101

PS Stratify -M4

0.5495

0.6370

0.7890

PS Matching -M1

0.4967

0.6137

0.7638

PS Matching -M2

0.5042

0.6314

0.7897

PS Matching -M3

0.4901

0.6227

0.7882

PS Matching -M4

0.4986

0.6160

0.7663

PS Covariate Adjust - M1

0.5067

0.6374

0.7900

PS Covariate Adjust - M2

0.4970

0.6493

0.8078

PS Covariate Adjust - M3

0.4823

0.6511

0.8101

PS Covariate Adjust - M4

0.5117

0.6370

0.7890

Reg. Adjustment - M1

0.5070

0.6530

0.8257

Reg. Adjustment - M2

0.5013

0.7018

0.9014

Reg. Adjustment - M3

0.4862

0.6341

0.8128

Reg. Adjustment - M4

0.5166

0.7139

0.9065

42

Figure 3.1 AUC Estimates from different methods and different models
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Table 3.3 Bias in estimating AUC using Different PS models
True AUC
Models/Methods

0.5

0.7

0.9

Unadjusted

0.1293

0.0302

0.0532

PS Stratify -M1

0.0502

-0.0626

-0.1100

PS Stratify -M2

0.0488

-0.0507

-0.0922

PS Stratify -M3

0.0511

-0.0489

-0.0899

PS Stratify -M4

0.0495

-0.0630

-0.1110

PS Matching -M1

-0.0033

-0.0863

-0.1362

PS Matching -M2

0.0042

-0.0686

-0.1103

PS Matching -M3

-0.0099

-0.0773

-0.1119

PS Matching -M4

-0.0014

-0.0840

-0.1337

PS Covariate Adjust - M1

0.0067

-0.0745

-0.1243

PS Covariate Adjust - M2

-0.0030

-0.0751

-0.1150

PS Covariate Adjust - M3

-0.0177

-0.0854

-0.1187

PS Covariate Adjust - M4

0.0117

-0.0709

-0.1227

Reg. Adjustment - M1

0.0070

-0.0470

-0.0743

Reg. Adjustment - M2

0.0013

0.0018

0.0014

Reg. Adjustment - M3

-0.0138

-0.0659

-0.0872

Reg. Adjustment - M4

0.0166

0.0139

0.0065
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Table 3.4 Relative Bias in estimating AUC using different methods and different models
True AUC
Models/Methods

0.5

0.7

0.9

Unadjusted

25.8527

4.3076

5.9070

PS Stratify -M1

10.0387

-8.9477

-12.2259

PS Stratify -M2

9.7690

-7.2440

-10.2455

PS Stratify -M3

10.2277

-6.9815

-9.9870

PS Stratify -M4

9.9047

-8.9956

-12.3315

PS Matching -M1

-0.6688

-12.3302

-15.1365

PS Matching -M2

0.8322

-9.7960

-12.2543

PS Matching -M3

-1.9724

-11.0410

-12.4274

PS Matching -M4

-0.2886

-11.9942

-14.8570

PS Covariate Adjust - M1

1.3354

-10.6492

-13.8160

PS Covariate Adjust - M2

-0.6033

-10.7243

-12.7760

PS Covariate Adjust - M3

-3.5442

-12.1923

-13.1864

PS Covariate Adjust - M4

2.3374

-10.1260

-13.6343

Reg. Adjustment - M1

1.3956

-6.7087

-8.2597

Reg. Adjustment - M2

0.2647

0.2619

0.1545

Reg. Adjustment - M3

-2.7593

-9.4143

-9.6898

Reg. Adjustment - M4

3.3258

1.9813

0.7268
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Figure 3.2 Relative Bias in estimating AUC using different methods and different models
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Table 3.5 Standard error in estimating AUC using Different PS models
True AUC
Models/Methods

0.5

0.7

0.9

Unadjusted

0.0248

0.0222

0.0170

PS Stratify -M1

0.0641

0.0609

0.0490

PS Stratify -M2

0.0614

0.0580

0.0452

PS Stratify -M3

0.0610

0.0575

0.0447

PS Stratify -M4

0.0648

0.0616

0.0497

PS Matching -M1

0.0216

0.0209

0.0174

PS Matching -M2

0.0209

0.0199

0.0159

PS Matching -M3

0.0213

0.0205

0.0164

PS Matching -M4

0.0221

0.0213

0.0177

PS Covariate Adjust - M1

0.0174

0.0167

0.0137

PS Covariate Adjust - M2

0.0173

0.0166

0.0133

PS Covariate Adjust - M3

0.0177

0.0171

0.0138

PS Covariate Adjust - M4

0.0173

0.0166

0.0136

Reg. Adjustment - M1

0.0186

0.0174

0.0130

Reg. Adjustment - M2

0.0186

0.0166

0.0096

Reg. Adjustment - M3

0.0184

0.0176

0.0133

Reg. Adjustment - M4

0.0187

0.0165

0.0094
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Table 3.6 Root Mean Squared Error in estimating AUC using different methods and models
True AUC
Models/Methods

0.5

0.7

0.9

Unadjusted

0.1316

0.0375

0.0558

PS Stratify -M1

0.0814

0.0874

0.1205

PS Stratify -M2

0.0785

0.0770

0.1027

PS Stratify -M3

0.0796

0.0755

0.1004

PS Stratify -M4

0.0816

0.0881

0.1216

PS Matching -M1

0.0219

0.0888

0.1373

PS Matching -M2

0.0213

0.0714

0.1114

PS Matching -M3

0.0235

0.0800

0.1130

PS Matching -M4

0.0222

0.0866

0.1349

PS Covariate Adjust - M1

0.0186

0.0764

0.1251

PS Covariate Adjust - M2

0.0176

0.0769

0.1158

PS Covariate Adjust - M3

0.0251

0.0871

0.1195

PS Covariate Adjust - M4

0.0209

0.0728

0.1235

Reg. Adjustment - M1

0.0198

0.0501

0.0755

Reg. Adjustment - M2

0.0186

0.0167

0.0097

Reg. Adjustment - M3

0.0230

0.0682

0.0882

Reg. Adjustment - M4

0.0251

0.0216

0.0114
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Figure 3.3 Root Mean Squared Error in estimating AUC using different methods and models
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Table 3.7 Coverage of 95% confidence intervals for AUCs using different PS models
True AUC
Models/Methods

0.5

0.7

0.9

Unadjusted

0.00

71.04

9.64

PS Stratify -M1

99.96

99.60

20.92

PS Stratify -M2

99.80

99.96

41.04

PS Stratify -M3

99.76

99.64

45.40

PS Stratify -M4

99.92

99.96

18.84

PS Matching -M1

91.76

2.08

0.00

PS Matching -M2

83.56

13.60

0.00

PS Matching -M3

78.96

11.28

0.00

PS Matching -M4

95.08

2.04

0.00

PS Covariate Adjust - M1

86.24

2.36

0.00

PS Covariate Adjust - M2

75.04

6.68

0.00

PS Covariate Adjust - M3

64.88

4.80

0.00

PS Covariate Adjust - M4

83.76

3.36

0.00

Reg. Adjustment - M1

93.36

22.32

0.00

Reg. Adjustment - M2

95.28

94.92

94.20

Reg. Adjustment - M3

87.96

3.32

0.00

Reg. Adjustment - M4

85.60

85.76

86.76
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CHAPTER 4: MODEL MISSPECIFICATION
In Chapter 3, we have shown that propensity score methods (stratification, matching and
covariate adjustment) resulted in biased estimation of the true AUC. We have also shown that the
direct AUC regression adjustment on the covariates lead to unbiased estimation of AUC under
certain circumstances. This is true especially when the covariates related to the outcome or all
measured covariates are included in the model.
The AUC regression adjustment is based on modelling the ROC curve as a function of
placement values to estimate the adjusted AUC, as described in Section 2.5. However, in
observational studies, little is known about the impact of misspecifying the model adjusting for
the AUC. Therefore, in this part of the dissertation research, we aim to assess model
misspecification in AUC regression adjustment. In other words, we sought to determine the
impact of incorrectly modelling the covariate effects on the risk effect estimate. We conducted a
simulation study to evaluate model misspecification in AUC regression adjustment. The
simulation study is designed to specifically illustrate the following aims: 1) The impact of
missing influential variables; 2) The impact of modelling continuous variables as dichotomous;
3) The impact of failing to include interactions; 4) and the impact of non-linearity.

4.1

Design of the simulation study

The data generating process is similar to those used in Chapter 3, Section 3.1. The
following have been simulated:
1) Three independent continuous covariates x1 , x2 , x3 . Each of the three covariate varies in their
association with the outcome and the risk factor group as described in the following table:

51
Table 4.1 Association between baseline covariates with risk group and outcome
Strongly associated Moderately associated
Weakly associated
with risk group
with risk group
with risk group
Strongly associated
with outcome

x1

Moderately
associated with
outcome

x2

Weakly associated
with outcome

x3

Hence, x1 is strongly associated with the risk group and the outcome; x2 is moderately
associated with the risk group and the outcome; and x3 is weakly associated with the risk group
and the outcome. For aims 1- 3 of this simulation, the strength of the association between a given
variable and the outcome is measured with the Pearson correlation. We consider correlations
values of 0.7, 0.4 and 0.1 to depict strong, moderate and weak association, respectively (Pett,
1997). Similarly, the association between the risk factor group and the covariates is measured by
the odds ratio. A strong, moderate or a weak association is defined as the odds of having the risk
factor is increased by a factor of 4.5, 2.5, and 1.5, respectively (Rosenthal, 1996).

Table 4.2 A guide to strength of association
Association
Correlation
Strong

.7 - .89

Moderate

.5 - .69

Weak

0 - .28

Source: Adapted from Pett, 1997
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2) A risk factor status Ti was generated such that the logit of the probability of having the
risk factor for the ith subject is linearly related to  x1 , x2 , x3  . The logit model is given by:

logit  0  1 x1   2 x2  3 x3

(4.1)

where 1  log  4.5 , 2  log  2.5 , 3  log(1.5) . The value of  0 was set according to the
specific aim under investigation. Hence, for each subject, a treatment status denoted by T was

 logit 
generated from a Bernoulli distribution with parameter  Ptreat  where Ptreat  exp 
 , i.e.
 1  logit 
T

Bernoulli  Ptreat  . T =1 if the subject has the risk factor and T=0 otherwise. The treatment

status vector is computed by comparing the estimated probability of assignment to a random
variable U generated from Uniform  0,1 . We assigned T  1 if U  Ptreat and T  0 if U  Ptreat .
3) A continuous response Yi was randomly generated as an outcome conditional on risk factor
status (Ti) and a set of independent covariates. The outcome is modelled specific to the aim under
investigation. More details are given in section below.

4.2

Data Simulation

A sample of size N = 500 was considered for this simulation with 1,500 replications. The
data generating process was done according to the methods in section 4.1 to specifically illustrate
the following four aims:
4.2.1 Aim1: The impact of missing influential variables
To examine the impact of missing influential variables, for each of the N subjects, we generated
three independent covariates  x1 , x2 , x3 

Normal (0,1) according to Table 4-1. We generated a
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treatment status for each subject based on the logit model in Equation (4.1).  0 was set to 0 so
that approximately 50% of subjects would be exposed to the risk factor group. This was
determined in an initial set of Monte Carlo simulations. The true outcome model is generated
using the following linear model:
Yi   0   T  1 x1   2 x2  3 x3  

(4.2)

N  0, 4  . The regression coefficients were determined according to Equation (3.9).

where 

Thus, 1  3.92,

 2  1.75, 3  0.4 . We set  0  0 . The effect on outcome of risk group

compared to non-risk group is quantified by the AUC statistic through  in Equation 4-2 using
the relationship     * 2 1  AUC0  as described in Equation (3.12). We considered three
different values of AUC0 in the outcomes-generating process: 0.5, 0.7, and 0.9. These values
were set according to the general rule of interpreting AUC suggested by Hosmer and Lemeshow
(2000) to indicate no discrimination, an acceptable discrimination, and an excellent
discrimination, respectively (Hosmer & Lemeshow, 2000).
Under Aim1, we specifically sought to determine what would happen if the model is
missing:
a) A covariate strongly associated with the outcome. So, the investigative model is given
by: Yi   0   T  1 x1   2 x2   3 x3   i .
b) A covariate moderately associated with the outcome? ( Yi   0   T  1 x1   3 x3   i )
c) A covariate weakly associated with the outcome? ( Yi   0   T  1 x1   2 x2   i )
d) Covariates moderately and weakly related to the outcome? ( Yi   0   T  1 x1   i )
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4.2.2 Aim2: The impact of modelling continuous covariates as dichotomous.
To evaluate the effect of modeling continuous variables as dichotomous, the data generating
process is the same as in section 4.2.1 and the true outcome model is exactly similar to Equation
(4.2). We investigated the following models:
a) A covariate strongly associated with the outcome is dichotomized i.e. x1 is dichotomized
as D1 .The research model is Yi   0   T  1D1   2 x2  3 x3   i
b) A covariate moderately associated with the outcome is dichotomized: x2 is dichotomized
as D2 ( Yi   0   T  1 x1   2 D2  3 x3   i
c) A covariate weakly associated with the outcome is dichotomized: x3 is dichotomized as

D3 ( Yi   0   T  1 x1   2 x2  3 D3   i )
d) All three covariates are dichotomized i.e. x1 , x2 , x3 are dichotomized as D1 , D2 , D3

Yi  0   T  1D1   2 D2  3 D3   i  .

4.2.3 Aim3: The impact of excluding interactions
To evaluate the impact of missing interactions in model misspecification, we consider the
following outcome model with interaction effects:

Yi   Ti  1 x1   2 x2  3 x3  1 x1 x2   2 x1 x3  3 x2 x3   i
where 

N  0, 4  and x1 , x2 , x3

(4.3)

Normal 1,1 are independent variables associated with the

outcome strongly, moderately, and weakly, respectively. In this setting x1  x3 have mean 1
rather than 0 so that they would not be centered. Not centering the variables would effectively
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eliminate the association between main terms and interactions terms. We refer to the independent
terms, x1 , x2 , x3 as “main terms” and x1 x2 , x1 x3 , x2 x3 as ‘interaction terms’. To keep things
simple, the coefficients of the interaction terms in Equation 4-3 were set to be the same
coefficients as we would have used for the main effects for strong, moderate and low association.
The regression coefficients

1 ,  2 , 3 were determined using Equation 3-9. We set

1  3.92,  2  1.75 ,  3  0.4 and  0  0 .  0 in Equation 4.1 was set to -2.83 so that
approximately 50% of the subjects would be exposed to the risk factor group. The interaction
terms are likely to be correlated with the main effect terms as seen in Table 4.3; this is referred to
as multicollinearity. However, we believe multicollinearity can safely be ignored in this situation
as discussed by Woolridge in Introductory Econometrics (Wooldridge, 2000). Woolridge argues
that collineratity induced by two main effects and their interaction (for example x1, x2 and x1x2)
are not something to worry about as they are not linearly related. For instance both variables
should be included in the regression to capture the relation between the predictor and the
outcome as a function of another predictor.
Table 4.3 Correlation coefficients between outcome,
main effects and interactions terms
Pearson Correlation Coefficients
Y

x1

x2

x3

x1

0.7361

1

-0.0003

0.0002

x2

0.4653

-0.0003

1

0.0001

x3

0.1949

0.0002

0.0001

1

x1x2

0.8674

0.5772

0.5771

0.0001

x1x3

0.6143

0.5768

-0.0002

0.5766

x2x3

0.3985

-0.0001

0.5770

0.5770
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We evaluated the impact of interaction according to these investigative models:
a) Ignoring any interaction term with the strong covariate i.e.

Yi   Ti  1 x1   2 x2  3 x3  3 x2 x3   i
b) Ignoring any interaction term with the moderate covariate

Yi   Ti  1 x1   2 x2  3 x3   2 x1 x3   i
c) Ignoring any interaction term with the weak covariate i.e.

Yi   Ti  1 x1   2 x2  3 x3  1 x1 x2   i
d) Ignoring all interaction terms ( Yi   Ti  1 x1   2 x2   3 x3   i )

4.2.4 Aim 4: The impact of non-linearity
To evaluate the performance of model misspecification on nonlinear fitting, we consider the
following quadratic regression model:

Yi   Ti  1  x1  c1    2  x2  c2   3  x3  c3    i

(4.4)

where we generated x1 , x2 , x3 uniformly distributed from 0 to 4 and  i

N  0, 2.5 . The

2

regression coefficients

2

2

1 ,  2 , 3 were set to 6, 3, and 2 respectively to depict strong, moderate

and weak association between the outcome and the covariates. We used the Hoeffding’s D to
determine the correlations between x1 , x2 , x3 and Y. Unlike the Pearson and the Spearman
correlations, the Hoeffding’s D can be used to detect nonlinear dependency beyond linear and
monotonic association (Hoeffding, 1948) . The values of the statistic vary between -0.5 and 1,
with 1 indicating complete dependence. We also used a visual check to measure the strength of
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the association between Y and the covariates.  c1 , c2 , c3  in Equation 4-4 represent the lowest
points where the quadratic curve changes direction i.e. the vertex. We consider two sets of values
of  c1 , c2 , c3  resulting to two quadratic functions: a U-shaped curve and J-shaped curve with the
following respective models:

Yi   Ti  1  x1  1.95  2  x2  1.95  3  x3  1.95   i

(4.5)

Yi   Ti  1  x1  1.27    2  x2  1.27   3  x3  1.27    i

(4.6)

2

2

2

2

2

2

The risk status was generated for each subject based on the logit model in Equation (4.1) where
we set

0  5.75 to produce a 50/50 risk and non-risk factor group.

The relationships between the outcome and the covariates based on Equation (4.5) are given in
Figure 4.1 and Table 4.4 and those based on Equation (4.6) are given in Figure 4.2 and Table 4.5.
From the plots, we can clearly see that Plot A shows a strong relationship between Y and x1 as
the data points fall close to the line. Plots B and C indicate a moderate and a low relationship,
respectively. From the tables, x1 has the highest Hoeffding’s correlation, followed by x2 and
then x3 .
Figure 4.1 Plots of association between the outcome and the covariates using Equation (4.5)

Plot A

Plot B

Plot C
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Figure 4.2 Plots of association between the outcome and the covariates using Equation (4.6)

Plot A

Plot B

Plot C

Table 4.4 Correlation coefficients between the
Outcome and the covariates for Model 4.5
Hoeffding Dependence Coefficients
Y

x1

x2

x3

x1

0.1285

1

0

0

x2

0.0723

0

1

0

x3

0.0436

0

0

1

Table 4.5 Correlation coefficients between the
Outcome and the covariates for Model 4.6
Hoeffding Dependence Coefficients
Y

x1

x2

x3

x1

0.3797

1

0

0

x2

0.2856

0

1

0

x3

0.2140

0

0

1

59
Under Aim 4, we investigated the influence of modelling a covariate as linear when it is
in fact quadratic. We specifically look at the impact of the following models:
a) Modelling x1 as linear i.e. Yi   Ti  1  x1  c1    2  x2  c2   3  x3  c3    i
2

2

b) Modelling x2 as linear i.e. Yi   Ti  1  x1  c1    2  x2  c2   3  x3  c3    i
2

2

c) Modelling x3 as linear i.e. Yi   Ti  1  x1  c1    2  x2  c2   3  x3  c3    i
2

2

d) Modelling x1 , x2 , x3 as linear i.e. Yi   Ti  1  x1  c1    2  x2  c2   3  x3  c3    i

4.3

Estimation of Risk effect

The adjusted risk effect was estimated via AUC based on Janes et al.’s method (2009) for
accommodating covariates in ROC analysis as described in Chapter 2 and briefly in Section
3.6.5.
4.4

Evaluation criteria

Five criteria were used to evaluate the impact of model misspecification in AUC
regression adjustment. The first three are bias, relative bias and root mean square error (RMSE)
as defined in Sections 3.7.1 and 3.7.2. The other two criteria are the 95% confidence intervals
coverage and the type I error. The coverage was used to determine the proportion of times the
true mean was contained in the interval estimator. Using the normal approximation interval and
our 1,500 simulated data sets, any coverage less than 93.9% and greater than 96.1% is
statistically different from 95% as described in Section 3.6.3. The type I error was used to
determine the smallest possible error probability in rejecting the true null hypothesis. We fix the
level of the test to 0.05.
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4.5

Results of the simulation study

Results of the simulation study are given in Tables 4.6 to 4.10 and Figures 4.3 to 4.7.
When we examined the impact of missing influential covariates in Aim 1, the results of the mean
estimated risk effect across the 1,500 simulated data sets in Table 4.6 and Figure 4.3 showed that
the greatest bias is associated with leaving a strong covariate out. The relative bias ranged from
4.2% to 43.72% for AUC = 0.9 to 0.5, respectively. When the model was missing a moderate
covariate, the risk estimates were also biased but much less biased than the results with the
strong covariate. Furthermore, a model ignoring a covariate weakly related to the outcome did
not have a great impact on the estimated risk effect: In all three cases, the bias was almost null;
the coverage proportions were significantly less than 95%; and the type I error has the smallest
possible error probability of 5.53% . Another important finding is that the RMSE is greater when
there is no effect (AUC=0.5) compared to when true AUC is .7 or .9. Finally, modelling a strong
covariate alone leads to results similar to the model missing the moderate covariate.
When we examined Aim 2 i.e. what would happen if a continuous covariate is
categorized as dichotomous, the results in Table 4.7 and Figure 4.4 suggested that modelling a
weak continuous covariate as dichotomous has a superior fit than dichotomizing a moderate and
strong covariate. Among the four models in Aim 2, the worst is when all continuous covariates
are categorized as dichotomous: the model is associated with the greatest bias and a type I error
of 99.93%.
When we investigated the impact of leaving out interaction terms when in reality the true
model contains interactions (Aim 3), we found out that any model ignoring any interaction term
leads to biased estimates of the true AUC. The greatest biases were associated with models 1, 2,
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and 4 when leaving out strong, moderate and all interactions, respectively -See Table 4.8 and
Figure 4.5.
Finally, when we examined the effect of non-linearity by modelling a covariate as linear
when it is in fact quadratic, we note three important results. First, the U-shaped and the J-shaped
models produce the exact same results when the true models are misspecified as seen in Tables
4.9 and 4.10 and in Figures 4.6 and 4.7. Second, when the strong covariate and when all three
covariates were considered linear, the true estimates were greatly biased. Finally, to our surprise,
AUC of 0.5 is not associated with the greatest bias anymore as we have seen in Aims 1-3 but the
risk effect is most biased when AUC = 0.7 or 0.9.
In conclusion, it is far more damaging when misspecification involves a strong covariate
than to incorrectly model a covariate weakly associated with the outcome. Among all fitted
models from Tables 4.6 to 4.10 and Figures 4.3 to 4.7, the greatest bias is seen when there is no
effect (AUC=0.5) except when we incorrectly modelled the non-linear relationship. For the
“correct” models or “Model 0” in Tables 4.6 through 4.10 and Figures 4.3 to 4.7, we would
expect the models to perform best which is the case. However, the type I error are greater than
expected. We speculate that this might be due to the choice of bootstrapping method used in the
simulations, or the normality assumption in estimating the parametric AUC might be violated.
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Table 4.6 AIM 1 Simulation Results
Mean
True
Relative
Bootstrap
95% CI
Type I
Adjusted
Bias
RMSE
AUC
bias
Standard error
Coverage (%) Error (%)
AUC
Model 0: Real model including all 3 covariates
0.5
0.4918
-0.0082 -1.6322
0.0184
0.0201
91.60
8.40
0.7
0.6914
-0.0086 -1.2350
0.0166
0.0187
91.60
-0.9
0.8944
-0.0056 -0.6274
0.0098
0.0113
92.20
-Model 1: Model missing strong covariate
0.5
0.7186
0.2186 43.7164
0.0159
0.2192
0.00
100.00
0.7
0.8346
0.1346 19.2353
0.0124
0.1352
0.00
-0.9
0.9384
0.0384 4.2708
0.0070
0.0391
0.60
-Model 2: Model missing moderate covariate
0.5
0.5670
0.0670 13.4021
0.0184
0.0695
5.47
94.53
0.7
0.7446
0.0446 6.3756
0.0157
0.0473
20.47
-0.9
0.9135
0.0135 1.5045
0.0089
0.0162
62.47
-Model 3: Model missing weak covariate
0.5
0.5008
0.0008 0.1503
0.0181
0.0181
94.47
5.53
0.7
0.6976
-0.0024 -0.3403
0.0163
0.0164
94.13
-0.9
0.8964
-0.0036 -0.3956
0.0095
0.0102
94.13
-Model 4: Model including strong covariate only
0.5
0.5769
0.0769 15.3834
0.0181
0.0790
1.27
98.73
0.7
0.7517
0.0517 7.3822
0.0152
0.0539
10.27
-0.9
0.9163
0.0163 1.8082
0.0086
0.0184
50.40
--- Indicates Power = 100%
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Figure 4.3 Simulation Results for Aim 1
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Table 4.7 AIM 2 Simulation Results
Mean
True
Relative
Bootstrap
95% CI
Type I
Adjusted
Bias
RMSE
AUC
bias
Standard error
Coverage (%) Error (%)
AUC
Model 0: Real model including all 3 covariates
0.5
0.4918
-0.0082 -1.6322
0.0184
0.0201
91.60
8.40
0.7
0.6914
-0.0086 -1.2350
0.0166
0.0187
91.60
-0.9
0.8944
-0.0056 -0.6274
0.0098
0.0113
92.20
-Model 1:Covariate strongly associated with the outcome is dichotomized
0.5
0.5879
0.0879 17.5782
0.0180
0.0897
0.40
99.60
0.7
0.7500
0.0500 7.1442
0.0152
0.0523
12.47
-0.9
0.9082
0.0081 0.9052
0.0089
0.0121
79.07
-Model 2: Covariate moderately associated with the outcome is dichotomized
0.5
0.5090
0.0090 1.8008
0.0186
0.0207
91.67
8.33
0.7
0.7035
0.0035 0.5041
0.0166
0.0170
93.53
-0.9
0.8986
-0.0014 -0.1603
0.0097
0.0098
93.80
-Model 3: Covariate weakly associated with the outcome is dichotomized
0.5
0.4959
-0.0041 -0.8291
0.0183
0.0187
93.53
6.47
0.7
0.6942
-0.0058 -0.8239
0.0165
0.0174
93.33
-0.9
0.8954
-0.0046 -0.5147
0.0097
0.0107
92.80
-Model 4: All three covariates are dichotomized
0.5
0.6053
0.1053 21.0678
0.0178
0.1068
0.07
99.93
0.7
0.7626
0.0626 8.9433
0.0149
0.0643
3.87
-0.9
0.9135
0.0135 1.4996
0.0086
0.0160
61.73
--- Indicates Power = 100%
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Figure 4.4 Simulation Results for Aim 2
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Table 4.8 AIM 3 Simulation Results
Mean
True
relative
Bootstrap
95% CI
Type I
Adjusted
Bias
RMSE
AUC
bias
Standard error
Coverage (%) Error (%)
AUC
Model 0: Real model including all 3 interactions
0.5
0.4898
-0.0102
-2.0388
0.0185
0.0211
90.53
9.47
0.7
0.6883
-0.0117
-1.6684
0.0168
0.0204
89.40
-0.9
0.8919
-0.0081
-0.9006
0.0100
0.0129
89.33
-Model 1: Model ignoring strong interactions
0.5
0.6589
0.1589
31.7811
0.0185
0.1600
0.00
100.00
0.7
0.7496
0.0495
7.0784
0.0165
0.0522
16.33
-0.9
0.8534
-0.0466
-5.1764
0.0131
0.0484
3.00
-Model 2: Model ignoring moderate interactions
0.5
0.6527
0.1527
30.5472
0.0187
0.1539
0.00
100.00
0.7
0.7458
0.0458
6.5404
0.0168
0.0488
22.40
-0.9
0.8520
-0.0480
-5.3300
0.0134
0.0498
2.27
-Model 3:Model ignoring weak interactions
0.5
0.5154
0.0154
3.0772
0.0187
0.0242
86.60
13.40
0.7
0.6985
-0.0015
-0.2163
0.0168
0.0169
94.73
-0.9
0.8875
-0.0125
-1.3931
0.0105
0.0163
80.07
-Model 4: Model ignoring all interactions
0.5
0.6591
0.1591
31.8262
0.0185
0.1602
0.00
100.00
0.7
0.7499
0.0499
7.1252
0.0165
0.0525
16.00
-0.9
0.8538
-0.0462
-5.1389
0.0131
0.0481
3.47
--- Indicates Power = 100%
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Figure 4.5 Simulation Results for Aim 3
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Table 4.9 AIM 4 U-shaped Simulation Results
Mean
True
relative
Bootstrap
95% CI
Type I
Adjusted
Bias
RMSE
AUC
bias
Standard error
Coverage (%) Error (%)
AUC
Model 0: Real model including all covariates
0.5
0.5560
0.0560
11.2050
0.0181
0.0589
86.13
13.87
0.7
0.7433
0.0433
6.1812
0.0153
0.0459
21.87
-0.9
0.9183
0.0183
2.0316
0.0082
0.0200
40.93
-Model 1: Modelling x1 as linear
0.5
0.6567
0.1567
31.3338
0.0205
0.1580
0.00
100.00
0.7
0.7156
0.0156
2.2351
0.0184
0.0242
84.53
-0.9
0.7960
-0.1040 -11.5545
0.0148
0.1050
0.00
-Model 2: Modelling x2 as linear
0.5
0.5553
0.0553
11.0682
0.0187
0.0584
16.33
83.67
0.7
0.6692
-0.0308
-4.4040
0.0168
0.0351
55.00
-0.9
0.8112
-0.0888
-9.8670
0.0124
0.0897
0.00
-Model 3: Modelling x3 as linear
0.5
0.5336
0.0336
6.7136
0.0184
0.0383
54.60
45.40
0.7
0.6743
-0.0257
-3.6707
0.0167
0.0306
66.60
-0.9
0.8392
-0.0608
-6.7527
0.0117
0.0619
0.07
-Model 4: Modelling all 3 covariates as linear
0.5
0.6751
0.1751
35.0189
0.0195
0.1762
0.00
100.00
0.7
0.7244
0.0244
3.4901
0.0179
0.0303
69.40
-0.9
0.7906
-0.1094 -12.1606
0.0153
0.1105
0.00
--- Indicates Power = 100%
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Figure 4.6 Simulation Results for U-shaped Aim 4

70

Table 4.10 AIM 4 J-shaped Simulation Results
Mean
True
relative
Bootstrap
95% CI
Type I
Adjusted
Bias
RMSE
AUC
bias
Standard error
Coverage (%) Error (%)
AUC
Model 0: Real model including all covariates
0.5
0.5560
0.0560
11.2050
0.0181
0.0589
86.13
13.87
0.7
0.7433
0.0433
6.1812
0.0153
0.0459
21.87
-0.9
0.9183
0.0183
2.0316
0.0082
0.0200
40.93
-Model 1: Modelling x1 as linear
0.5
0.6567
0.1567
31.3338
0.0205
0.1580
0.00
100.00
0.7
0.7156
0.0156
2.2351
0.0184
0.0242
84.53
-0.9
0.7960
-0.1040 -11.5545
0.0148
0.1050
0.00
-Model 2: Modelling x2 as linear
0.5
0.5553
0.0553
11.0682
0.0187
0.0584
16.33
83.67
0.7
0.6692
-0.0308
-4.4040
0.0168
0.0351
55.00
-0.9
0.8112
-0.0888
-9.8670
0.0124
0.0897
0.00
-Model 3: Modelling x3 as linear
0.5
0.5336
0.0336
6.7136
0.0184
0.0383
54.60
45.40
0.7
0.6743
-0.0257
-3.6707
0.0167
0.0306
66.60
-0.9
0.8392
-0.0608
-6.7527
0.0117
0.0619
0.07
-Model 4: Modelling all 3 covariates as linear
0.5
0.6751
0.1751
35.0189
0.0195
0.1762
0.00
100.00
0.7
0.7244
0.0244
3.4901
0.0179
0.0303
69.40
-0.9
0.7906
-0.1094 -12.1606
0.0153
0.1105
0.00
--- Indicates Power = 100%
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Figure 4.7 Simulation Results for J-shaped Aim 4
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CHAPTER 5: APPLICATION
In the first part of this chapter, we apply different propensity score methods and models
to data from the Shock Research Unit at the University of Southern California, Los Angeles,
California. We also compare the propensity score results to corresponding results derived from
the AUC direct regression for estimating the adjusted AUC.
In the second part of the chapter, we examine model misspecification in AUC regression
by incorrectly modelling the covariates in the data.

Introduction
In the United States, there are more than 1 million admissions to emergency departments
annually due to shock, according to Merck (Merck, 2009). The medical disorder of shock is
mostly characterized by an abnormal low systolic blood pressure or hypotension. For people in
shock, the tissues of the body do not receive enough blood. As a result, the tissues with impaired
circulation suffer damage from lack of oxygen. Damage to tissues and organs of the body can
lead to severe disability or death of patients in shock.
In this data analysis, it is of primary interest to compare patients in shock with patients
not in shock upon admission to the shock research unit at the University of Southern California
in Los Angeles, California, in terms of diastolic blood pressure (DBP) at discharge. In other
words, we sought to study whether shock status at admission is a risk factor for diastolic blood
pressure at discharge. Because this is an observational study where subjects are assigned to one
of the risk factor groups in a non-random manner, there is a possibility that discharge diastolic
blood pressure in subjects with shock and non-shock is related to some baseline covariates such
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as demographic or physiological variables. In order to accurately estimate the risk effect, it is of
practical importance to account for those covariates. Failing to adjust for those variables could
lead to biased estimates of shock status effect on diastolic blood pressure at discharge.
Therefore, we illustrate our dissertation research findings by using different propensity
score methods and models to estimate the probability that the DBP response from the jth
randomly chosen patient in the shock group is less than that from the ith randomly selected
patient in the non-shock group. This is defined as P YNS  YS  where YS and YNS are diastolic
blood pressure measure for patients in shock and non-shock groups, respectively.

Methods
The data consists of 113 critically ill patients who were admitted to the Shock Research
Unit at the University of Southern California, Los Angeles, California. Data on many
physiological variables were collected successively in time on each patient. From the wealth of
data that was collected, the present data is a subset that appeared in the book “Statistical
Analysis: A computer Oriented Approach” by Afifi and Azen in 1979 for examples and exercises
purposes (Afifi & Azen, 1979). In this set, initial measurements (that is, measurements upon
admission) and final measurements on the same variables (that is, measurements just before
death or discharge) were collected. Hence, each patient has 2 records and each record contains
21 variables: 6 general variables and 14 physiological variables. The outcome of interest was
diastolic blood pressure at discharge, whereas the risk factor of interest was shock. A patient is
defined as having a shock if experiencing any of these shocks: hypovolemic shock, cardiogenic
shock, bacterial shock, neurogenic shock or other.
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For each subject, propensity scores (PS) were estimated by fitting a logistic regression to
predict shock, as a function of baseline covariates. We constructed four different PS models
including different combinations of measured covariates: PS model 1 (PS-M1) included
variables associated with the shock status group. The association between the covariates and the
shock group were determined using a t-test for continuous covariates and a chi-square test for
categorical variables at 5% significance level. PS model 2 (PS-M2) included variables associated
with the outcome, diastolic blood pressure. The association between the outcome and the
continuous covariates were measured using a Pearson correlation; and a t test is used to test
association between the outcome and the categorical covariates. PS model 3 (PS-M3) included
variables associated with both the risk factor group and the outcome i.e. all common covariates
to the previous two models. PS model 4 (PS-M4) included all measured variables.
As described in Section 3.4, strata were created based on the quintiles of the estimated
propensity scores; and also matched pairs of subjects in shock and not in shock were created
using the 1:1 greedy matching technique with calipers of width 0.2 of the standard deviation of
the logit of the propensity score.
Two analyses were carried out: The first analysis comprised all measured variables while
the second analysis included only uncorrelated variables. The reason for the second analysis was
to more closely mimic the simulations, which assumed uncorrelated variables. Four different
methods were used to estimate the adjusted AUC in diastolic blood pressure at discharge. First,
subjects were stratified based on the quintiles of the propensity score and the adjusted AUC was
computed as described in section 3.5.2. Second, we estimated the adjusted shock effect via AUC
in the propensity score matched sample as described in Section 3.5.3. Third, the risk group effect
is estimated under the covariate adjustment on the propensity score method using the method
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described in 3.5.4. Finally, for comparison purposes, we used the direct AUC regression method
to adjust for covariates in directly modelling covariates effects on the response as described in
3.5.5. For this method, we considered 4 separate regression models as well where each model is
described above.
Furthermore, the issue of model misspecification in AUC regression method was
investigated. Eight different models were used: these models included 4 models missing
influential variables and 4 models where continuous variables were modelled as dichotomous.
The estimated AUCs were computed and then compared to the adjusted AUC obtained from our
“best” model.
Results
The study sample consisted of n=113 critically ill subjects of whom 79 (69.91%) where
in shock and 34 (30.09%) were not in shock upon admission to the shock research unit. Table 5.1
shows the summary statistics of the baseline covariates between subjects in shock and not in
shock. Subjects in the two groups were compared using pooled t-tests and chi-square tests for
continuous and dichotomous variables, respectively. The descriptive analysis reveals that
patients in shock have lower values of mean arterial pressure, systolic and diastolic pressure
upon admission (p<0.0001, p<0.0001 and p = 0.0042, respectively). Heart rate beats and mean
circulation time tend to be higher in those in shock than those not in shock (all p-value <0.05).
Surprisingly, the urinary output is almost three times higher in patients not in shock compared to
patients in shock (p=0.0019). There was no statistical difference between the two groups of
patients in regards to age, mean central venous pressure, body surface index, appearance time,
red cell index, hemoglobin, hematocrit and gender.
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Table 5.1 Baseline Characteristics of the Study Sample by Shock Group

Shock

No-shock

Total

P-value

Pearson r

N = 79
(69.91%)

N =34
(30.09%)

N=113

Age (years)

55.1 ± 16.9

53.4 ± 15.9

54.6 ± 16.6

0.6114

-0.0483

Systolic Pressure (mm Hg)

97.8 ± 28.9

127.6 ± 23.4

106.2 ± 30.7

<.0001

0.4577

Mean arterial pressure (mm
Hg)

68.2 ± 21.6

85.5 ± 18.1

73.4 ± 22

<.0001

0.3625

Heart rate (beats/min)

108.8 ± 28.1

94.3 ± 31.0

104.4 ± 29.6

0.0158

-0.2265

Diastolic pressure (mm Hg)

55.3 ± 18.8

66.1 ± 15.7

58.5 ± 18.5

0.0042

0.2676

Mean central venous
pressure (cmH2O)

9.1 ± 5.5

8.4 ± 6.2

8.9 ± 5.7

0.5272

-0.0601

Body surface index (m2)

1.7 ± 0.2

1.7 ± 0.8

1.7 ± 0.2

0.4165

0.0772

Cardiac index (liters/min
m2)

2.36 ± 1.4

3.1 ± 1.5

2.6 ± 1.5

0.0190

0.2203

Appearance time (sec)

10.78 ± 5.0

8.9 ± 4.3

10.2 ± 4.9

0.0570

-0.1796

Mean circulation time (sec)

24.1 ± 10.8

19.7 ± 9.0

22.8 ± 10.5

0.0391

-0.1944

Urinary output (ml/hr)

33.2 ± 79.0

103.7 ± 156.6

54.4 ± 112.3

0.0019

0.2888

Plasma volume index
(ml/kg)

47.0 ± 15.7

52.9 ± 13.5

48.8 ± 15.2

0.0579

0.1789

Red Cell Index (ml/kg)

21.1 ± 9.4

22.0 ± 7.1

21.4 ± 8.7

0.6444

0.0439

Hemoglobin (gm/100 ml)

11.6 ± 2.6

11.0 ± 2.2

11.4 ± 2.5

0.2834

-0.1018

Hematocrit (percent)

35.3 ± 8.1

33.9 ± 7.1

34.9 ± 7.8

0.3687

-0.0854

Male

38 (48.10 %)

21 (61.76 %)

59 (52.21%)

-0.1255

-0.1255

Female

41 (51.90 %)

13 (38.24 %)

54 (47.79%)

Variable

Sex

Continuous variables are reported as mean ± standard deviation. Dichotomous variables are reported as
frequency and percent.

77
The selection of the variables entering the different PS models is summarized in Table 5.2.
The number of covariates in the PS models range from 3 to 16. Logistic regression is used to
estimate the propensity scores and the c-statistic, a measure known to measure model fit for
logistic regression is also reported. The unadjusted model doesn’t contain any variable; it has a cstatistic value of 0.7174. The PS-M1 contains 7 covariates with a c-statistic of 0.85; PS-M2 has 6
variables and a c-statistic of 0.826; PS-M3 contains 3 covariates with c-statistic of 0.812; and
finally PS-M4 contains all 16 variables and has a c-statistic of 0.895.
The crude AUC between shock groups was 0.7174. We obtain a 95% confidence interval for
the unadjusted AUC of (0.61-0.82) using the Delong formula incorporated into SAS PROC
LOGISTIC. Since the confidence interval does not contain the null value 0.5, we conclude that
for two randomly chosen patients from the shock and non-shock groups, the probability that the
DBP response from the participant in the non-shock group exceeds that the response from the
patient in the shock group is estimated to be 71.74%. In other words, there is a significant chance
that the DBP of those in the non-shock group is greater than that of those in the shock group.

78
Table 5.2 Selection of variables entering different propensity score models
Covariates
PS model 1 PS model 2 PS model 3 PS model 4
Age (years)









Systolic Pressure (mm Hg)









Mean arterial pressure (mm Hg)









Heart rate (beats/min)









Diastolic pressure (mm Hg)









Mean central venous pressure (cmH2O) 







Body surface index (m2)









Cardiac index (liters/min m2)









Appearance time (sec)









Mean circulation time (sec)









Urinary output (ml/hr)









Plasma volume index (ml/kg)









Red Cell Index (ml/kg)









Hemoglobin (gm/100 ml)









Hematocrit (percent)









Sex









The adjusted estimates using four different methods are reported in Table 5.3. Using
stratification on the quintiles of the propensity score, the adjusted estimates of P YNS  YS 
range from 0.6337 to 0.6833 for different PS models. The standard error and the confidence
interval were obtained using Equation 3-18. In contrast to the unadjusted AUC, all four 95 per
cent confidence intervals contain the null value of 0.5. This indicates that under stratification, the
adjusted AUC is not statistically different from the null value i.e. we fail to reject

H o : AUC  0.5 .
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Propensity score matching resulted in the formation of 22, 26, 28 and 21 pairs of subjects
in shock and not in shock for PS models 1, 2, 3, and 4 respectively. The adjusted estimates range
from 0.599 to 0.675. The standard error and the 95% confidence interval were obtained using
1000 bootstrap samples of the original observations. The results are not consistent under this
method as some confidence intervals contain the null value and some do not.
Using covariate adjustment on the propensity score, inconsistency of the results is similar
to what we found with matching. The standard errors were also estimated based on 1000
bootstraps.
The fourth method consisting of using the AUC regression to directly model the
covariates on the response resulted in values of adjusted AUC close to each other ranging from
0.596 to 0.639. All four confidence intervals estimated based on bootstrap are consistent and
contain the null value of 0.5.
From the results of the Monte Carlo simulations described in Section 3.7, we found the
crude estimate is biased positively when true AUC is around 0.5 and 0.7. Hence, the crude
estimate in this application is most likely overestimated. Furthermore, we found out that
stratifying, matching and covariate adjustment on the propensity score resulted in biased
estimation of AUC. Thus, in our illustration study, these estimates obtained from the propensity
score methods and models are likely subject to a great deal of bias. Given the results and the
recommendations of our simulations, our best estimate of the true risk effect is most likely the
estimate obtained from model 2 using the direct AUC regression adjustment. Hence the adjusted
estimate of the probability that the DBP response from the jth randomly chosen patient in the
shock group is less than that from the ith randomly patient in the non-shock group i.e.

P YNS  YS  is 0.6224; the 95% CI based on 1,000 bootstrap samples is (0.4633, 0.7919). Since
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the confidence interval includes 0.5, there is no statistical evidence that shock status upon
admission is a risk factor for diastolic blood pressure.

Table 5.3 Effect estimates from different methods and models
Models/Methods
AUC
SE

95%CI

Unadjusted

0.7174

0.0529

0.6138 - 0.8210

PS Stratify -M1

0.6734

0.1478

0.3837 - 0.9630

PS Stratify -M2

0.6404

0.1239

0.3975 - 0.8833

PS Stratify -M3

0.6833

0.1209

0.4463 - 0.9204

PS Stratify -M4

0.6337

0.1599

0.3203 - 0.9471

PS Matching -M1

0.59902

0.0867

0.4330 - 0.7728

PS Matching -M2

0.67498

0.07423

0.5314 - 0.8224

PS Matching -M3

0.6698

0.0700

0.5349 - 0.8094

PS Matching -M4

0.64918

0.0825

0.4888 - 0.8120

PS Covariate Adjust - M1

0.62574

0.08133

0.4712 - 0.7900

PS Covariate Adjust - M2

0.64133

0.06598

0.5128 - 0.7714

PS Covariate Adjust - M3

0.64756

0.0629

0.5265 - 0.7731

PS Covariate Adjust - M4

0.6117

0.07937

0.4550 - 0.7661

Reg. Adjustment - M1

0.60579

0.08173

0.4467 - 0.7670

Reg. Adjustment - M2

0.62241

0.08382

0.4633 - 0.7919

Reg. Adjustment - M3

0.63894

0.07523

0.4917 - 0.7865

Reg. Adjustment - M4

0.59619

0.09238

0.4208 - 0.7829

In the second part of our data illustration, we aim to explore model misspecification. The
“best” model is considered as the model containing the 6 variables associated with the outcome
(Regression adjustment Model 2). Each of these variables varies in their association with the
response DBP according to the Pearson correlations values and their classification in Table 5.4.
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Table 5.4 Classification of baselines covariates based on their association with outcome
Pearson r

Strong
Covariates

Moderate
Covariates

Weak
Covariates

Variable
Age (years)

-0.01490

Systolic Pressure (mm Hg)
Mean arterial pressure (mm
Hg)
Heart rate (beats/min)
Diastolic pressure (mm
Hg)
Mean central venous
pressure (cmH2O)
Body surface index (m2)
Cardiac index (liters/min
m2)
Appearance time (sec)

0.47679

-0.29073











































-0.10126







Mean circulation time (sec)

-0.13453







Urinary output (ml/hr)
Plasma volume index
(ml/kg)
Red Cell Index (ml/kg)

0.15508













0.03015







Hemoglobin (gm/100 ml)

0.12164







Hematocrit (percent)
-0.12310
Sex

0.13331







-0.12550













Female

0.52209
0.03178
0.52558

0.31300
0.04843

-0.19066

Hence, systolic, diastolic and mean arterial pressure are strongly related to outcome (r
ranging from 0.48 to 0.53 and p-values are highly significant, p<0.0001). Mean central venous
pressure and body surface index are moderately associated with DBP: r value close to 0.3.
Finally, plasma volume index is weakly related to DBP, r = -0.19 and p-value = 0.0431.
The estimates of P YNS  YS  in model misspecification are given in Table 5.5. When we
examined the impact of missing influential covariates, the greatest bias was associated with
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leaving the strong covariates out. The estimated AUC was 0.736 with a 95% CI of (0.6253,
0.8436). There’s not much harm in leaving a weak covariate out. These results were consistent
with our findings from the Monte Carlo simulations.
From our simulations results in Section 4.5, we found that modelling a weak covariate as
dichotomous has a superior fit than modelling a strong covariate as dichotomous. The findings in
our case study are consistent with those of the simulations study. The worst model in
dichotomization is modelling all covariates as dichotomous when they are in fact continuous.
From the case study, we conclude that it is far more damaging to incorrectly model
covariates strongly associated with the outcome than to incorrectly model covariates weakly
associated with the outcome. These findings were consistent with previous findings in our Monte
Carlo simulations.
Table 5.5 Effect Estimates from Model Misspecification
Models
AUC

SE

95%CI

Best model

0.6224

0.0838

0.4633 - 0.7919

Missing strong covariates

0.7360

0.0557

0.6253 - 0.8436

Missing moderate covariates

0.6463

0.0798

0.4917 - 0.8045

Missing weak covariates

0.6168

0.0811

0.4627 - 0.7806

Including strong covariates only

0.6389

0.0752

0.4917 - 0.7865

Strong covariates are dichotomized

0.7083

0.0651

0.5815 - 0.8367

Moderate covariates are dichotomized

0.6262

0.0817

0.4681 - 0.7883

Weak covariates are dichotomized

0.6182

0.0843

0.4595 - 0.7899

All covariates are dichotomized

0.7074

0.0694

0.5719 - 0.8441

For our second analysis, a subset of covariates not correlated with each other was
selected using the Pearson correlation criteria. A total of 6 variables was considered as compared
to 16 variables in the previous analysis – See Table 5.6-.
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Table 5.6 Pearson Correlation Coefficients, N = 113
MAP
HR
Mean arterial pressure in mm Hg
1
-0.0702
Heart rate in beats/min
-0.0702
1
Mean central venous pressure in
-0.0778 0.05307
cmH2O
Cardiac index in liters/min m2
0.04001 -0.0296
Body surface index in m2
0.21098 -0.0464
Red Cell Index in ml/kg
0.04198 -0.0398

MCVP
CI
BSI
RCI
-0.0778 0.04001 0.21098 0.04198
0.05307 -0.0296 -0.0464 -0.0398
1

0.00248

0.0763

-0.0566

0.00248
1
0.0763 0.0494
-0.0566 -0.1206

0.0494
1
-0.0462

-0.1206
-0.0462
1

The selection of the variables entering the different PS models is summarized in Table 5.7.
The number of covariates in the PS models range from 1 to 6. Hence, the PS-M1 contains 3
covariates; PS-M2 has 3; PS-M3 contains 1 covariate; and finally PS-M4 contains all 6
uncorrelated variables.

Table 5.7 Selection of variables entering different propensity score models
Covariates
PS model 1 PS model 2 PS model 3



Mean arterial pressure (mm Hg)



Heart rate (beats/min)
Mean central venous pressure



(cmH2O)



Body surface index (m2)



Cardiac index (liters/min m2)



Red Cell Index (ml/kg)

PS model 4







The adjusted AUC estimates were given in Table 5.8. Stratifying on the quintiles of the
propensity score yield to adjusted AUCs ranging from 0.62 to 0.67. Under the stratification
method, all four 95% confidence intervals contain the null value of 0.5 which indicate that there
is no significant chance that the DBP of those in the non-shock group is greater than that of those
in the shock group.

84

Table 5.8 Effect estimates from different methods and models
Models/Methods
AUC
SE
95%CI
Unadjusted
0.7174 0.0529 0.6138 - 0.8210
PS Stratify -M1
0.6223 0.136 0.3557 - 0.8889
PS Stratify -M2
0.6717 0.1103 0.4555 - 0.8879
PS Stratify -M3
0.6573 0.1397 0.4485 - 0.8661
PS Stratify -M4
0.6300 0.1397 0.3561 - 0.9039
PS Matching -M1
0.6209 0.0810 0.4669 -0.7846
PS Matching -M2
0.6196 0.0725 0.4778 - 0.7619
PS Matching -M3
0.6206 0.0722 0.4779 - 0.7608
PS Matching -M4
0.6768 0.0744 0.5339 - 0.8257
PS Covariate Adjust - M1 0.6301 0.0675 0.5013 - 0.7661
PS Covariate Adjust - M2 0.6693 0.0535 0.5668 - 0.7764
PS Covariate Adjust - M3 0.6717 0.0540 0.5684 - 0.7799
PS Covariate Adjust - M4 0.6315 0.0697 0.4999 - 0.7730
Reg. Adjustment - M1
0.6685 0.0625 0.5471- 0.7919
Reg. Adjustment - M2
0.6770 0.0557 0.5697 - 0.7880
Reg. Adjustment - M3
0.6661 0.0521 0.5643 - 0.7686
Reg. Adjustment - M4
0.6831 0.0668 0.5532 - 0.8149

For propensity score matching and covariate adjustment on the propensity score methods,
the adjusted AUCs range from 0.62 to 0.68. The standard error and the 95% confidence interval
were obtained using 1000 bootstrap samples of the original observations. The results are not
consistent under these two methods as some confidence intervals contain the null value and some
do not. For AUC regression adjustment, the values of the adjusted AUCs are very close to each
other and close to 0.67. All confidence intervals are consistent and do not contain the null value
of 0.5. Hence, we conclude that there is a significant probability that DBP when in shock status
is greater than DBP when in no-shock status.
The results obtained from the propensity score methods in this second analysis are
consistent with those obtained from the first analysis. However, with the regression adjustment
method, it appears that correlation between variables has a great effect on the estimate of the
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adjusted AUC: The AUC estimates were not significant different from 0.5 when the covariates
were correlated but they were significant when the covariates were uncorrelated. Given these
findings, correlation between covariates should be taken into account when estimating AUC
through regression adjustment. One may also speculate that the difference between the two
analyses might be due to the fact that the first analysis included more covariates (up to 16) while
the second analysis included only a maximum of 6 covariates and we know that excluding
covariates can lead to incorrect answers.
In the second part of this second analysis, we explore model misspecification. From the
recommendations of the simulations study, we consider the “best” model to be model 2 for
Regression Adjustment in Table 5.8. This model refers to the model containing the 3 variables
associated with the outcome. Each of these three variables varies in their association with the
response DBP according to the correlations values and their classification in Table 5.4.
Therefore, mean arterial pressure is strongly related to outcome (r=0.52) while mean central
venous pressure and body surface index are moderately associated with DBP (r ~ 0.3). There was
no variable weakly associated with the outcome in this subset analysis. The AUC estimates from
model misspecification are given in Table 5.9. We notice that the greatest harm is associated
with leaving a strong covariate out as compared to leaving a moderate covariate out. These
results were consistent with our findings from the Monte Carlo simulations.
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Table 5.9 Effect Estimates from Model Misspecification
Models
AUC
SE
Best model
0.67699 0.0557
Missing strong covariates
0.721
0.053
Missing moderate covariates
0.666
0.052
Including strong covariates only
0.666
0.052
Strong covariates are dichotomized
0.694
0.055
Moderate covariates are
0.666
0.054
dichotomized
All covariates are dichotomized
0.687
0.054

95%CI
0.5697 - 0.7880
0.616- 0.824
0.564 - 0.769
0.564- 0.769
0.586 - 0.803
0.561 - 0.772
0.582 - 0.791

Furthermore, we investigated the effect of dichotomizing continuous variables in model
misspecification. We found that modelling a strong continuous covariate as dichotomous is
worse than dichotomizing a moderate covariate. The results also suggest that it is not a good idea
to dichotomize continuous covariates in AUC regression adjustment.
These findings all lead to the same conclusion that there is an evidence that there is a
significant chance that the DBP in the non-shock group is greater than the DBP in the shock
group. The results were also consistent with those in the Monte Carlo simulations.
Finally, we conclude that incorrectly modeling covariates in AUC regression adjustment
lead to unbiased estimates of the true effect.
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CHAPTER 6: DISCUSSION
6.1

Conclusion

In the first part of this dissertation research, the primary objective was to evaluate the
performance of propensity score methods to estimate the area under the ROC curve while
controlling for confounding. The simulation study demonstrated that when AUC is used as
measure of risk factor effect, conditioning on the propensity results in biased estimation of the
true effect. When the true effect was null i.e. AUC was 0.5, matching on the propensity score and
covariate adjustment on the propensity score were associated with less bias compared to the
method of stratifying on the propensity score. When the true effect was different from the null
effect, the estimated AUC were all associated with large bias for all different methods.
In a simulation study conducted by Austin et al. (2007), they found that controlling for
covariates using propensity score methods when estimating conditional odds ratio and
conditional hazard ratio resulted in biased estimation of the true effect (P. C. Austin et al., 2007)
. Thus our results are not totally unexpected. This study is the first to evaluate the performance of
different propensity score methods for estimating area under the ROC curve i.e. P YRF  YNRF  .
Due to the increased interest in epidemiologic research to report P YRF  YNRF  as the measure
of association and to the use of propensity score methods to control for confounding, it is of
practical importance that the statistical properties of propensity scores estimators for AUC be
understood.
A secondary objective was to determine the best choice of variables to include in the
propensity score model. We found that when matching and covariate adjustment on the
propensity score methods are used, the propensity score model including variables associated

88
with outcome seems to have the least bias. Models including those variables that are both
associated with outcome and risk group (these are referred to as true confounders) did not
perform well. But these findings are not conclusive because the results were not consistent
throughout the true effects and the amount of bias is still high. In prior research investigating the
issue of variables selection in propensity score models, Brookhart et al. (2006) found that a
propensity score model with only covariates associated with outcome or the true confounders
resulted in a larger number of matched and a smaller mean squared error (Brookhart et al., 2006)
Furthermore, Austin found that variables associated with treatment exposure but not the outcome
increased the MSE of the estimated relative risk (Austin, 2008) .
A third objective was to compare the performance of the propensity score approach with
that of a conventional regression approach to estimate P YRF  YNRF  . The results of our
simulation study show that the AUC regression model including all covariates associated with
outcomes has the best performance and resulted in unbiased estimates of the risk effect.
However, regression models that did not include all variables associated with outcome and only
contained variables associated with risk factor group or variables associated with both risk group
and outcome resulted in biased estimates of the true AUC and in an increased MSE. Austin et al.
(2007) advocate that the choice between propensity score methods and regression adjustment
when estimating odds ratio or hazard ratio should be based on whether one wishes to estimate the
marginal or the conditional treatment effect. They noted that the conventional regression
adjustment estimates conditional treatment effect while the propensity score estimates marginal
treatment effects (P. C. Austin et al., 2007).
Finally, in the second part of this research, the goal was to investigate the impact of
model misspecification in the conventional AUC regression adjustment. These modelling errors
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include omitting covariates, dichotomizing continuous variables, modelling quadratic covariates
as linear, and excluding interactions terms from the model. We found that the greatest bias was
associated with the model that omitted a covariate strongly associated with the outcome. And in
general, it is far more damaging to incorrectly model a strong covariate than to incorrectly model
a covariate weakly associated with the outcome. The results of this study suggest that researchers
must focus on these variables known to be strongly related to the outcome variable and should
attempt to correctly model them.
Given these findings, we do not recommend the use of propensity score methods to
provide adjusted estimates of P YRF  YNRF  . Instead the conventional AUC regression
adjustment is the method to use. When the outcome variable is continuous, if one is interested in
using the propensity score methods, then the difference in means allows for unbiased estimation
of the risk effect. When the conventional AUC regression adjustment is used to control for
confounding, analysts must focus on variables related to the outcome; these covariates
(especially if they are strongly associated with the outcome) should be correctly modelled in
order to estimates accurate effect when assessing relationship between exposures and outcome.
Furthermore, leaving out important variables in AUC regression models could lead to biased
estimates of the true effect. Therefore, researchers and epidemiologists must make an effort to
identify significant risk factors.

6.2

Limitations

A limitation to the use of the propensity score methodology in practice includes the fact
that it only controls for observed variables. The unobserved variables are accounted for only
if they are correlated with the observed covariates. Although the baselines covariates were
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assumed to be correctly measured in the Monte Carlo simulations, this assumption in practice
can be more problematic. Another limitation is in the choice of true AUC. The true effect of
AUC was limited to 0.5, 0.7 and 0.9. Perhaps, the performance of the adjusted AUC should
also be evaluated on a wider range of true effect. Other limitations include considering cases
where the outcome variable is normally distributed. The effect of sample size on the
performance of the proposed methods should have also been investigated. Here, only one
sample size was used (N=500). Also, we assumed equal numbers of people with and without
the risk factor. Different prevalences could have had an influence on results. Also, only
independent variables were considered in this research; we could have considered correlated
variables as well. We also looked at cases where the standard deviations between the risk and
non-risk groups are equal; perhaps we should have also considered cases where the standard
deviations between the two groups are not equal. Finally, all possible types of
misspecification of the covariates have not been considered. Perhaps, other ways to model
curvilinear association should have been considered.
6.3

Future Work

Future work in this area should focus on estimating the area under the curve under the
non-normal assumption and on identifying if the propensity score methods performs well if we
sought to estimate the “marginal” area under the ROC curve. This will involve defining a new
measure based on the AUC used in the current research which will be referred to as the
“marginal” area under the ROC curve (Austin 2007a). For future research, perhaps we should
expand on nonlinear modelling errors beyond quadratic relationships; and on interaction models
where the interactions terms are more independent i.e. not based on combination of strong,
moderate and weak. In the future, we should also investigate the effect of sample size and the
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prevalence of case-control on the performance of the adjusted AUC. For example, does it
perform well for fairly small samples? We should also investigate the effect of prevalence of
case and control in estimating AUC as well as the effect of different variance estimates between
the two groups.
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APPENDIX
A. BALANCE DIAGNOSTICS & SIMULATION CHECK

The correctness of the simulated data was checked by, for a single dataset of size N=500,
whether:
a. Approximately 50% of subjects are exposed to the risk factor by computing the
frequency of the risk factor status.
Risk Factor Status
T
Frequency
0
251
1
249

Percent
50.2
49.8

b. The covariates are imbalanced at baseline by computing a standardized difference
between subjects with risk factor and subjects without risk factor for each covariate in
the data.

Table A.1 Standardized difference comparing the mean or prevalence
of baseline covariates between risk factor groups
Continuous Standardized
Binary
Standardized
covariates
difference
covariates
difference
c1

0.337

b1

0.286

c2

0.182

b2

0.169

c3

0.001

b3

0.004

c4

0.331

b4

0.288

c5

0.182

b5

0.166

c6

0.000

b6

0.002

c7

0.331

b7

0.287

c8

0.180

b8

0.165

c9

0.001

b9

0.002
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A standardized difference greater than 0.1 is considered as a significant difference in the mean or
prevalence of a covariate between risk factor groups (Normand et al., 2001).

c. The distribution of the propensity score “reasonably” overlap by computing a cstatistic to predict if the distributions of the PS overlap (Westreich, Cole, Funk,
Brookhart, & Sturmer, 2011). Westreich reported a high-c statistic in the propensity
model is “neither necessary nor sufficient for control of confounding”.
The values of the C-statistic in the propensity score model including variables related to
treatment; all covariates, binary covariates only, and continuous covariates only were 0.753,
0.756, 0.666 and 0.696, respectively. These values of the c-statistic are considered “reasonable”
since they are neither too high nor too low. (Recall the c-statistic takes on values between 0.5
and 1).

d. The two risk factor groups are comparable i.e. if the overall distribution of the estimated
propensity score within each risk group “reasonably” overlap.. We checked this via
histograms.
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Figure A.1 Distribution of the estimated propensity score in each
risk factor group

The estimated propensity score “reasonably” overlap which means the risk factors and the nonrisk factors groups are comparable.

e. Balance for the measured covariates is achieved between the risk factor and the nonrisk factor groups by 1) Assessing the balance of each covariate after adjustment by
computing a standardized difference; and 2) Summarizing the distribution of the
propensity scores via box plots: If they overlap then a good balance is achieved.
This property is checked using two propensity score methods: 1) Propensity score matching to
check balance of the covariates after adjustment in the PS matched sample and 2) Stratification
on the propensity using the technique of box plots.
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Table A.2 Standardized difference comparing the mean or prevalence of variables between risk
factor groups after PS adjustment by matching technique
Continuous Standardized
Binary
Standardized
covariates
difference
covariates
difference
c1

0.012

b1

0.039

c2

0.095

b2

0.013

c3

0.053

b3

0.105

c4

0.009

b4

0.039

c5

0.066

b5

0.026

c6

0.089

b6

0.184

c7

0.058

b7

0.013

c8

0.035

b8

0.026

c9

0.046

b9

0.079

After adjustment in the propensity score matched sample, all the covariates have a standardized
difference less than 0.1 except b6. Hence, balance is achieved for almost 95% of the baseline
variables.

Figure A.2 Graphical analysis for balance diagnostics in stratifying the quintiles of the PS
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The distribution of the estimated propensity score appears to be similar within the two risk
groups. Given this graphical evidence, we conclude that stratifying on the quintiles of the
propensity scores resulted in the creation of subjects who are balanced in observed covariates
between the two risk factor groups.

f. The association between the risk factor group and the covariates depicts an odds ratio
of log(2) and log(1.5) for binary variables and log(1.5) and log(1.25) for continuous
variables by computing the odds ratio between the risk factor and each covariate in
the data.
Table A.3 Odds Ratio Estimates of the simulated data
Odds Ratio Estimates
Variable Point estimate Variable Point estimate
b1
2.00
c1
1.51
b2
1.51
c2
1.25
b3
1.01
c3
1.00
b4
2.01
c4
1.50
b5
1.51
c5
1.25
b6
1.00
c6
1.00
b7
2.00
c7
1.50
b8
1.50
c8
1.25
b9
1.00
c9
1.00

We clearly see that  b1 , b4 , b7   2 ,  b2 , b5 , b8   1.5 ,  c1 , c4 , c7   1.5 , and  c2 , c5 , c8   1.25 . This is
what was expected. Hence, our data have been correctly generated.
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g. The association between the outcome and the covariates depicts a correlation of 0.5
for strong and 0.3 for moderate by computing the correlations between the
independent variables and the outcome.
Table A.4 Correlation coefficients between outcome and the simulated continuous covariates
Outcome Y
c1
0.498
-0.001 -0.001 -0.001 -0.001 -0.001 -0.001 -0.001 -0.001
c2
0
0.498
0
0
-0.001
0
0
0
0
c3
-0.001
-0.001 0.498 -0.001 -0.002 -0.002 -0.001 -0.001 -0.001
c4
0
-0.001 -0.001 0.309 -0.001 -0.001 -0.001 -0.001 -0.001
c5
0.001
0
-0.001
0
0.309
0
0
0
0
c6
0.001
0
-0.001
0
0
0.309
0
0
0
c7
0
0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001
c8
0
0
0
0
0
0
0
0
0
c9
0.001
0.001 0.001 0.001 0.001 0.002 0.001 0.001 0.001

Table A.5 Correlation coefficients between outcome and the simulated dichotomous covariates
Outcome Y
b1
0.497
-0.001 -0.003 -0.002 -0.002 -0.002 -0.002 -0.002 -0.002
b2
0.001
0.499
0
0
0
0
0
0
0
b3
0
0.001 0.499 0.001 0.001 0.001 0.001 0.001 0.001
b4
0
0
0
0.309
0
-0.001
0
0
0
b5
-0.001
0
0
0
0.309
0
0
0
0
b6
0
0
0
0
0
0.309
0
0
0
b7
0
0
0
0
0
0
0
0
0
b8
0.001
0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001
b9
0
0
0
0
0.001
0
0
0
0
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Table A.6 Correlation coefficients between the simulated covariates
b1
b2
b3
b4
b5
b6
c1
0
0.001
0
0.001 -0.001
0.001
c2
0
-0.001 -0.002
0
0
-0.002
c3
-0.001
0.001
0
0.001 0.001
0
c4
-0.001
0
0.001
0
0.001
-0.002
c5
0.001
-0.002
0.001 -0.001
0
0.004
c6
-0.001
0.001
0
0.001
0
0
c7
0
-0.001 -0.001
0
0
0.001
c8
0.001
0
-0.001 -0.001
0
-0.001
c9
0
0.001
0
0.001 -0.002
0

b7
0.001
0
0.002
0
-0.001
-0.001
0.001
-0.001
-0.002

b8
0
-0.002
0.001
0
0
0
-0.001
0
0

b9
0.001
0.001
0
-0.001
-0.001
0
0.002
0
0

These correlations values are expected. Furthermore, the correlations values in Table 3-10 show
that the covariates are uncorrelated with each other thus independent. This demonstrates once
again that our data has been correctly generated.

h. The outcome based on a single dataset is approximately normal by 1) Overlaying a
normal PDF on a histogram; and 2) Constructing a Q-Q plot. If the data are sample
from the normal distribution, then the points on the plot tend to fall along a straight
line (Chambers et al. 1983).
Figure A.3 Distribution of the outcome based on a single dataset
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i. The sample mean AUC based on 2500 replications is approximately normal by 1)
Overlaying a normal PDF on a histogram; and 2) Constructing a Q-Q plot. If the data
are sample from the normal distribution, then the points on the plot tend to fall along
a straight line (Chambers et al. 1983).

Figure A.4 Distribution of the AUC sample mean across 2500 datasets
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B. SAS CODES
B.1 SAS Code to compute the “Stratified “adjusted AUC
*Using Stratification on the PS, for each PS model, we will compute the stratum specific AUC
along with its std. error;
%macro StratifiedAUC (data,title,outcome);
proc sort data =&data; by quintile; run;
proc logistic data = &data;
ods select none ;
by quintile;
model anyshock = &outcome; *(event='Women');
roc 'DBP2' &outcome; *To output auc and its std error;
ods output ROCAssociation= Raucs;
ods output ResponseProfile= Rfreq;
Title "Logistic model to estimate the stratum specific AUC for: &title";
Run;
Data AUCStratum (Keep = Quintile Area StdErr Outcome Count);
set Raucs;
set Rfreq;
call symput ('AUC', area);
call symput ('StdErr', StdErr);
call symput ('Shock', Count);
call symput ('Noshock', Count);
run;
Data AUCStratum ;
set AUCStratum;
length NewShock $14;
if Outcome = 0 then NewShock = 'Shock'; else NewShock = 'Noshock';
run;
*The adjusted AUC and its std error is caluclated using the weighted average of the stratum
specific AUCs: Ws = ms*ns/sum(ms*ns);
proc sql;
title "Adjusted AUC as the weighted average of the stratum-specific AUCs";
create table Abc as
select one.Quintile,
one.Count as shock, two.Count as Noshock, one.area as auc, one.StdErr as
stderr,
one.Count*two.Count as numerator,
sum(one.Count*two.Count) as denominator,
one.Count*two.Count/sum(one.Count*two.Count)as weight,
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one.area*(one.Count*two.Count/sum(one.Count*two.Count)) as
StratumAUC
from AUCStratum as one INNER JOIN AUCStratum as two
On (one.Quintile = two.Quintile)
where one.NewShock = 'Shock' and two.NewShock = 'Noshock';
quit;
proc sql;
create table Aa as
select *,
sum(StratumAUC) as AdjAUC,
weight*stderr as StratumSE,
sum(calculated StratumSE) as AUCSE,
(calculated AdjAUC) - 1.96*(calculated AUCSE)as LLCI,
(calculated AdjAUC) + 1.96*(calculated AUCSE)as ULCI
from Abc;
Quit;
Data StratifiedAUC (keep = AdjAUC AUCSE LLCI ULCI);
set AA;
where Quintile = 1;
ods select all;
proc print data = StratifiedAUC noobs; format AdjAUC 5.4 AUCSE 5.4 LLCI 5.4 ULCI 5.4 ;
title "The Adjusted Stratified AUC is for: &title";
run;
%mend;
* Example of macro call;
%StratifiedAUC(Ps_dataM1, PS model 1, dbp2);
B.2 SAS Code to compute the adjusted AUC using the concept of placement values
/*
The aAUC %macro is based the COMPROC command developed by
Janes, Longton & Pepe, 2008 for accommodating covariates in ROC analysis.
Description
The aAUC macro estimates the area under the ROC curve using the concept of placement values
while adjusting for covariates.
The placement values (PV) are estimated parametrically assuming a normal distribution. The
process is conducted in two steps. First, estimate the cumulative distribution (CDF) of the
response Y in the control group as a function of Z (i.e. the covariates of interest to adjust for).
This is done by specifying a linear model (Y = Bo + B1Z + e) assuming the error term is
normally distributed and the covariates act linearly on the distribution of Y. Then for each
subject i in the risk factor (or “disease”, or “treatment”, or “case”, or “condition” or “event”)
group, compute the placement values. The PV is the standard normal CDF of (Y - Bo_hat -
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B1_hatZ)/sd, where Bo_hat, B1_hat, and sd are the regression coefficients estimates and the
standard deviation of the control observations, respectively. The second step is to estimate the
adjusted AUC by computing the mean of the estimated placement values.
The inputs are: data, T, outcome adjcov, bsamp, n
adata = specifies the dataset to be used for analysis.
bT = specifies the variable denoting the risk factor (or “case” or
“disease” or “treatment”) group. T has the values 0/1.
coutcome = specifies the continuous response arising from the
populations with and without the risk factor.
dadjcov = specifies the covariates to adjust for.
en = number of covariates to adjust for.
fbsamp = number of bootstrap samples to be drawn for estimating standard
errors and Cis of the the adjusted AUC.
*/
%macro aAUC (data, T, outcome, adjcov, n, bsamp);
*
+***************************************************************************+
Computing the placement values and the adjusted AUCs for each replicate (SampleID)
*
+***************************************************************************+;
* +-------------------------------------------------------------------------+
*Step 1: running an OLS regression to estimate the CDF of Y in the control group
* +------------------------------------------------------------------------+;
proc reg data=&data (where =(&T =0))outest=OutEst;
By SampleID;
model &outcome = &adjcov/noprint;
title "Linear model to estimate the CDF of Y in the control group";
run;
*Read in the data where only the regression coefficients are computed and "renaming" the
variables;
Data RegCoef (Drop = _MODEL_ _DEPVAR_ &outcome &adjcov i) ;
set OutEst;
if _TYPE_ = 'PARMS';
array cov{&n} &adjcov;
array coef{&n} coef1-coef&n;
do i = 1 to &n;
coef{i}=cov{i};
end;
run;
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*Preparing the case data and creating a new variable _Type_ to merge on;
Data Case (Keep = SampleID &T &outcome _TYPE_ &adjcov);
Set &data (where =(&T =1));
_TYPE_ = 'PARMS';
run;
*Merging the regression coefficients data with the case data;
data CaseData ;
merge RegCoef Case;
by _TYPE_;
run;
* +------------------------------------------------------------------------+
Step 2: Estimating the placement values for each subject in the risk factor.
* +------------------------------------------------------------------------+;
data PVdata (Keep = SampleID &T &outcome _RMSE_ Intercept z1-z&n meancontrol PV);
set CaseData;
array cov{&n} &adjcov;
array coef{&n} coef1-coef&n;
array covcoeff{&n} z1-z&n;
do i =1 to &n;
covcoeff{i} = cov{i}*coef{i};
end;
meancontrol = intercept + sum(of covcoeff {*});
PV = PROBNORM((&outcome - meancontrol)/_RMSE_);
run;
* +-------------------------------------------------------------------------+
Step 3: Estimating the mean of the placement values i.e. the Adjusted AUC.
* +------------------------------------------------------------------------+;
proc means data = PVdata noprint;
By sampleID;
var PV;
output out = AdjAUC0 mean= AdjAUC var = AUCVar std = AUCStd;
run;
* +**************************************************************************+
Computing the variance and standard deviation for each adjusted AUC via Bootstrap
*
+**************************************************************************+;
proc sort data = &data;
by SampleID T;
run;
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%let MyData = &data;
proc surveyselect data=&MyData seed=1
out=BootSS
method=urs samprate=1
reps=&bsamp
outhits;
strata sampleID T; *To maintain prevalence of case and control as in the original data;
run;
* Redoing steps 1, 2, 3 above with the bootstrap sample;
* +------------------------------------------------------------------------+
*Step 1: running an OLS regression to estimate the CDF of Y in the control group
* +------------------------------------------------------------------------+;
proc reg data=BootSS (where =(&T =0))outest=OutEst1;
By SampleID;
model &outcome = &adjcov/noprint;
title "Linear model to estimate the CDF of Y in the control group";
run;
*Preparing the case data and creating a new variable _Type_ to merge on;
Data Case1 (Keep = Replicate SampleID &T &outcome _TYPE_ &adjcov);
Set BootSS (where =(&T =1));
_TYPE_ = 'PARMS';
run;
*Read in the data where only the regression coefficients are computed and "renaming" the
variables;
Data RegCoef1 (Drop = _MODEL_ _DEPVAR_ &outcome &adjcov i) ;
set OutEst1;
if _TYPE_ = 'PARMS';
array cov{&n} &adjcov;
array coef{&n} coef1-coef&n;
do i = 1 to &n;
coef{i}=cov{i};
end;
run;
*Merging the regression coefficients data with the case data;
data CaseData1 ;
merge RegCoef1 Case1;
by _TYPE_;
run;
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* +------------------------------------------------------------------------+
Step 2: Estimating the placement values for each subject in the risk factor.
* +------------------------------------------------------------------------+;
data PVdata1 (Keep = Replicate SampleID &T &outcome _RMSE_ Intercept z1-z&n
meancontrol PV);
set CaseData1;
array cov{&n} &adjcov;
array coef{&n} coef1-coef&n;
array covcoeff{&n} z1-z&n;
do i =1 to &n;
covcoeff{i} = cov{i}*coef{i};
end;
meancontrol = intercept + sum(of covcoeff {*}s);
PV = PROBNORM((&outcome - meancontrol)/_RMSE_);
run;
proc datasets library=work;
delete CASE1 CASEDATA1;
run;
quit;
* +------------------------------------------------------------------------+
Step 3: Estimating the mean of the placement values i.e. the Adjusted AUC.
* +------------------------------------------------------------------------+;
proc sort data = PVdata1; by sampleID Replicate ; run;
proc means data = PVdata1 noprint;
By sampleID Replicate ;
var PV;
output out = AdjAUCint mean= AdjAUC var = AUCVar std = AUCStd;
run;
proc means data = AdjAUCint VARDEF = N noprint;
By sampleID ;
var AdjAUC;
output out = AdjAUC1 mean= AdjBootMean var = AUCBootVar std = AUCBootStd;
run;
Data adjustedAUC;
merge adjauc0 adjauc1;
By SampleID;
T_crit = tinv(1-&alphalev/2, &bsamp-1);
LB_N = AdjAUC - T_crit*AUCBootStd; *Normal Distribution CI;
UB_N = AdjAUC + T_crit*AUCBootStd;
run;
%mend aAUC;
* Example of macro call;
%aAUC(shockdata, shockStatus, dbp2, SBP MAP HR DBP CI MCT UO, 7, 1000);
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